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CHAPTER I  
 
 
 
INTRODUCTION 
 
 
 
Overview 
 Radiofrequency ablation (RFA) has gained widespread acceptance in the 
treatment of liver tumors, particularly those tumors that are unresectable.  Despite the 
increasing clinical usage of RFA, technical challenges remain in achieving complete 
ablation of tumors.  In hepatic applications, RFA produces ablation zones that are limited 
in size both as a result of tissue properties as well as constraints in ablation device design 
and physics.  Because RFA is a focal therapeutic modality, proper placement of the RF 
device is an important goal in producing successful treatment in which the resulting 
ablation extents overlap the detectable tumor as well as a suitably defined margin which 
might contain undetected disease.  Achieving this goal requires planning in a manner that 
takes into account the known physical processes which govern RF ablations.  It also 
depends on the ability to target the device accurately to a desired location.  Both of these 
objectives are linked, however.  Indeed, accurate placement depends on having a 
predefined plan. In turn, a robust plan must account for the limitations in targeting 
accuracy.  Although, these objectives have been explored in the literature as separate 
problems, little has been done to create a treatment planning framework which accounts 
for both the physics of ablation as well as the targeting constraints in device placement. 
This dissertation research studied this problem by applying computational modeling and 
image-guided techniques to RFA.  In Chapter II, a method will be presented to search for 
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needle placement that best satisfies a therapeutic goal given outcomes predicted by finite 
element models of ablations.  The technique will be applied to simulated scenarios 
involving single as well as multiple ablations. In Chapter III, a phantom system will be 
developed to test ablation experiments using a tracked RFA.  A design for the tracked 
device as well as a means of calibrating the tracked device will be described.  The 
positional information from the tracked device will be fed into the model produced in 
Chapter II to quantify the model accuracy in predicting the spatial extents of the ablations 
within the phantom.  Metrics to quantify the model accuracy will be introduced, and the 
effects of potential tracking inaccuracies will be analyzed.  Finally, in Chapter IV, the 
sensitivity of predicted ablations to needle placement inaccuracies will be studied 
theoretically.  A novel technique will be introduced that couples boundary element and 
finite element methods to obtain multiple simulations efficiently for different needle 
placements over a static mesh.  The technique will be coupled to Monte Carlo 
simulations to generate a spatial map of the likelihood of ablation success.  The 
numerical method will then be used to study sensitivity of ablation outcomes near vessels 
to misplacement of the RFA device. 
 
Background and Significance 
 
 
Clinical relevance  
In 2002 the World Health Organization estimated 628,000 new primary liver 
tumor cases globally [1], of which hepatocellular carcinoma (HCC) is the most common 
type.  Worldwide, HCCs rank as the fifth most frequent solid tumor and the fourth most 
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common cause of cancer related mortality annually [2], with predominance especially in 
Asian and African nations [3].  Patients with HCCs, if left untreated, have a 5 year 
survival rate less than 5% [4, 5].  In the United States, HCCs are uncommon, but 
metastatic tumors arising from extrahepatic primary tumors are prevalent.  The liver is a 
common site for metastatic disease from extrahepatic primary tumors, particularly from 
other gastrointestinal tumors, because the liver drains venous blood from all other 
abdominal organs [6].  A major source of these metastases comes from colorectal tumors, 
the second most common tumor type in the US with an estimated 146,000 new cases in 
2004 [7].  An estimated 50% of these patients will develop metastases in the liver, and if 
left untreated, have average survival rates of 6 to 12 months [8].   
In both HCC and metastatic disease to the liver, the current conventional 
treatment with curative intent is surgical resection [9].  Surgery can potentially provide 
curative outcomes for both HCC and hepatic metastases [8, 10], with 5 year survival rates 
between 20-40% [4], especially if a 1 cm negative margin can be achieved [11, 12].  
Nevertheless, only 10-15% of patients with metastatic disease and less than 30% of 
patients with HCC are eligible candidates for surgical resections.  Clinical reasons for 
excluding patients from liver resections include inadequate functional hepatic reserves, 
proximity of tumors to vascular and biliary structures, multifocal lesions, as well as other 
underlying liver diseases [13]. 
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RFA mechanism 
 
Figure I-1: Diagram depicting closed electrical circuit in RFA procedure, reproduced from [14]. 
Radiofrequency ablation (RFA) is currently a widely used treatment modality for 
unresectable hepatic tumors [15].  Among the advantages of RFA over other thermal 
ablative therapeutic modalities are its cost-effectiveness [16] and its low complication 
rates [17, 18].  3 year survival rates have recently been reported at 50-70% for RFA 
treated patients [19].   As shown in Figure I-1, RFA works by inserting electrodes 
directly into a cancerous lesion.  Typically this procedure is performed under image 
guidance such as ultrasound.  Depending on the RFA system, additional metallic tines 
may then be deployed.  A radiofrequency voltage source (typically, 400-500 kHz) is then 
applied to the electrodes relative to large dispersive grounding pads.  Consequently, 
mobile ions in the tissue surrounding the electrodes attempt to travel in the alternating 
directions of the electric field.  It is the movement of these ions by electrical conduction 
that raises the temperature of the surrounding tissue through resistive heating, which in 
turn causes focal thermal damage to the tissue.  In a typical application of RFA, 
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temperatures reach upwards of 100°C in the immediate areas around the active 
electrodes.  Larger volumes of ablation around the electrodes are achieved chiefly by heat 
conduction from the zones surrounding the electrodes [20].  At supra-physiologic 
temperatures (above 45-50°C), tumors undergo coagulative necrosis, which is irreversible 
cellular damage caused by denatured proteins and disrupted cellular membranes.  Cell 
death is considered instantaneous at around 60°C  [4, 21-23].   
 
RFA of large tumors 
A major goal of current ablation research is in achieving larger ablations [24].  
Various commercial RFA systems have been well documented for their capacity to 
produce spherical ablation zones of 3 cm in diameter [25].  Although the underlying 
therapeutic mechanisms among these systems are in principle the same, there are 
differences in needle design and control of power delivery.  Newer electrode and RF 
generator designs can reportedly achieve ablation sizes as large as 5-7 cm in diameter, 
with each RFA procedure lasting approximately 10-15 minutes.  In order to maintain 
sufficient power density within the target tissue, some electrodes are cooled internally 
and designed to infuse saline to maintain tissue conductivity [26].  More recently, 
methods have been explored to achieve larger ablations by simultaneously applying 
power to multiple RFA probes [27]. 
Despite these improvements in RFA system design, there have been limited 
successes in applying RFA towards the treatment of large tumors, typically greater than 3 
cm in diameter given current RFA technology [28-30].  Attempts to treat large tumors, as 
reported in the literature, usually result in high local recurrence rate of the tumor.  RFA 
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achieves optimal results when treating tumors that are smaller than the maximum ablation 
size.  Because, as is done in surgical cases, an additional treatment margin of 0.5-1.0 cm 
around the tumor needs to be treated in order to reduce local recurrence, tumors that are 
comparable in size to the ablation volume usually are not treated adequately.  In a recent 
report in which tumors larger than 5 cm in diameter were treated with ablation zones of 3 
cm in diameter, the success rate was lower than 50% [29].  The other known limitation of 
RFA is the failure to treat tumors that are close to thermal sinks.  In particular, nearby 
vessels as small as 3mm in diameter can produce inadequate treatment [31-33].  This 
effect is described in Figure I-2.  
 
 
Figure I-2:  Incomplete treatment of tumor surrounded by blood vessels.  a) A preoperative CT shows the 
location of the tumor near large hepatic veins.  b) Initial treatment reveals defects in the ablation zone, 
manifesting as irregular borders.  c) Nine months later, a CT study reveals local recurrence as shown by 
arrows.  d)  Ablations were performed to treat recurring tumors.  Image reproduced from [32]. 
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Figure I-3:  a) Wireframe model of an inscribed regular dodecahedron with a sphere placed at the center of 
one of its faces.  b)  Solid model showing 6 overlapping ablation spheres arranged in a regular octahedron, 
with a cutaway depicting the tumor. c)  A cylindrical ablation strategy in which cubes tile the treatment 
volume and ablation spheres are placed circumscribing each cube.  Figures are reproduced from [34, 35]. 
Image guided techniques 
One hypothesized factor contributing to the inadequate treatment of tumors is 
inadequate guidance and monitoring of the RFA procedure.  During RFA, surgeons rely 
heavily on 2D intraoperative ultrasound (IOUS) for guidance and limited treatment 
monitoring [23].  Nevertheless, few studies have been performed to evaluate the accuracy 
of 2D IOUS guidance to position the RFA probe at the center of the tumor.  In one study, 
Scott et al. reported 4.2 ± 1.4 mm and 3.5 ± 1.6 mm discrepancies between the pathologic 
ablation center and the center of a tumor-mimic created in porcine liver [36].  Accurate 
localization becomes important in particular when parts of the tumor are not visible under 
IOUS.  Typically, an initial ablation causes gas bubble formation. The gas produces a 
highly echogenic effect with IOUS, which results in acoustic shadowing of all tissue deep 
to the ablation.  If additional ablations are required, IOUS may no longer be able to detect 
residual tumor.  Other investigators have studied ways to improve localization of the 
RFA probe inside the tumor.  Certain methods attempt to overcome the limitations of 2D 
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visualization inherent to IOUS by adopting 3D imaging modalities [37, 38].  Results 
using 3D imaging retrospectively to evaluate IOUS targeting showed that off-centered 
needle placement could sometimes escape detection with IOUS [39].   
Other methods use preoperative images registered to the physical space of the 
operating field as a means of intraoperative guidance [40, 41].  This technique takes 
advantage of the higher resolution and contrast of MRI or CT images for accurate probe 
placement.  By tracking the location of the RFA needle in physical space, its 
corresponding location in preoperative image space can be determined.  The utility of this 
image-guided method depends, however, on achieving accurate registration of images 
with an organ that has few rigid anatomical landmarks, deforms nonrigidly [42] and may 
move substantially during the operation, whether due to breathing or due to the surgical 
procedure itself [43]. 
 
Planning algorithms for ablation 
A few attempts have been made to devise a treatment planning system for 
ablation therapy.  Butz et al. formulated a nonlinear optimization problem to select the 
optimal ablation zone locations [44].  Ablations zones were modeled as spheres or 
ellipsoids.  Their method involved optimizing an objective function based on weighted 
sums of the ablated volume within the prescribed treatment volume and the ablated 
volume of healthy tissue outside of the treatment volume.  The weights were selected 
based on the sensitivity of healthy critical structures near the tumor.  Villard et al. 
similarly used ellipsoidal ablation zones to cover a given treatment volume by 
maximizing the number of tumor voxels covered [45].  In addition, however, the 
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investigators allowed constraints on allowable trajectories so that the ablation probe does 
not place through critical structures.  Another innovation was to model the heat-sink 
effects of liver vasculature by dynamically deforming the ellipsoidal ablation zones 
depending on their proximity to large vessels [46], and using the deformed shapes in 
optimizing placement.  This deformation was achieved phenomologically, however, 
without relying on any specific model of the underlying physical processes. 
Dodd et al. described a different approach using geometric analysis in order to 
place spherical ablation zones in such a way as to cover a spherical treatment volume 
completely [34].  They were able to demonstrate that spheres placed in specific patterns 
around the treatment volume could cover spherical treatment volumes up to 1.66 times 
the diameter of the ablation zone.  Their results further revealed that for a 66% increase 
in diameter, 14 ablations would be required to be placed in precise locations, illustrating 
the potential logistical limitations of using overlapping spheres.  Other strategies were 
based on using columns of ablations to achieve cylindrical ablation zones.  Multiple 
cylindrical ablations were then used to cover the tumor.  Khajanchee et al. also adopted a 
similar geometric approach using spherical ablation zones and treatment volumes [35].  
Rather than attempt to cover the entire spherical treatment volume, however, this method 
assumed that complete ablation of the surface of the sphere would result in complete 
necrosis of the tumor.  A polyhedron was inscribed into the treatment volume, and 
ablation zones were then placed at the center of each polyhedral face.  Investigators were 
careful to note that the imprecision of current localization made use of these treatment 
plans risky.   
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A common theme in most current planning literature for RFA is the use of 
multiple geometric shapes to cover another simple geometric shape.  Typically, these 
shapes are spheres or ellipsoids.  However, the number of spheres required to ablate a 
large treatment region increases dramatically with size.  This observation is corroborated 
by  theoretical results from the discrete and computational geometry literature on packing 
and covering theory [47-50].  In this theoretical analysis, the primary focus is given to 
deriving theoretical limits to the density of coverage for a given domain and the 
congruent shapes used to cover it, as well as estimating the computational complexity of 
the problem [51].  However, the applicability of these results towards treatment planning 
remains unclear. 
Finally, experimental validations have been conducted to fit in vivo ablation data 
to geometric models [52].  These studies employ geometric primitives (e.g. ellipsoids) to 
fit the radiological or pathological margins of the ablation.  Although this study indicates 
that a simple shape can be used to fit ablation zones, it fails to address whether there is 
predictive value when applied to tumors near other local tissue heterogeneity such as 
blood vessels or when other needle designs are used. 
 
Computational modeling of RFA 
Despite the intuitive appeal of the geometric planning algorithms, they do not 
directly account for the critical physical processes known to affect ablation shapes, such 
as power delivery, thermal diffusion, or the heat sink effects of blood perfusion, 
especially in the presence of nearby vessels greater than 3 mm.  In order to address these 
shortcomings, computational models of the physical processes in ablation are required.  
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Computational models have played an integral part in understanding the limitations of 
RFA treatment in large tumors, especially the roles that electrical and thermal properties 
of the liver have in affecting ablation size [53].  Models of thermal ablation typically 
solve Pennes bioheat equation [54] to obtain the temperature field within a region of 
interest resulting from a local heat source: 
 
 ( )b a RFTc k T h T T Qtρ
∂
= ∇ ⋅ ∇ − − +
∂
, (1.1) 
 
 
where QRF (W/cm2) is the heat source; T (°C) is the temperature; k (W/cm K) is thermal 
conductivity; ρ (g/cm3) is the tissue density; and c (J/g K), is the heat capacity.  The 
convective heat transfer coefficient, hb (W/cm3/K) models the rate of perfusion in the 
tissue, as arterial blood enters the tissue at a given temperature, Ta (°C), and is assumed to 
equilibrate immediately with the surrounding tissue.  In RFA, the heat source QRF can be 
computed in two steps.  First the electrostatic potential Φ is obtained by solving 
Laplace’s equation with appropriate boundary conditions: 
 
 - 0σ∇ ⋅ ∇Φ =  (1.2) 
 
 
where σ is the conductivity of the medium.  From a solution of the potential, the heat 
source resulting from ohmic heating can then be estimated as the time-averaged power 
density generated by the resulting current: 212RFQ σ= ∇Φ .  [55] 
  
12 
Published numerical models of RFA vary in complexity.  In a linear model, the 
distribution of electrical RF energy being deposited in a region is independent of the 
temperature distribution [56].  Nonlinear models have been developed, however, that take 
into account observed temperature-dependent effects on both thermal and dielectric 
properties [57-60].  Although not reported specifically for RFA, thermal ablative models 
may also incorporate changes in blood perfusion rate [61].  One common strategy to 
updating temperature-dependent material properties is to employ an Arrhenius model to 
estimate the amount of thermal damage [57], and to update the properties as a function of 
damage over time. 
Even though sophisticated finite element models of RFA have been described, 
little attention has been paid to date towards experimental validation of the models 
specifically for RF energy sources.  Nor has much work been done towards applying the 
models for planning needle placement.  These problems have been explored for other 
thermal ablative modalities, however.  In particular, planning based on finite element 
models have been described for cryosurgical applications [62-64].  Of interest are the 
shared features between cryosurgical planning and RFA planning, notably the need to 
place multiple ablation devices such that an objective function, based on the predicted 
temperature, is maximized within a region of interest.  These investigators studied a 
number of technical issues regarding coupling finite models of ablation with numerical 
optimization methods.  Of interest are their emphases on objective function design and 
development of strategies to reduce the computational burden, often employing 
phenomological methods to fit temperature distributions, and search heuristics to arrange 
and evaluate the device placements. 
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CHAPTER II  
 
 
 
OPTIMIZING NEEDLE PLACEMENT USING FINITE ELEMENT MODELS IN 
RADIOFREQUENCY ABLATION PLANNING 
 
 
 
Abstract 
Conventional radiofrequency ablation (RFA) planning methods for identifying 
suitable needle placements typically use geometric shapes to model ablation outcomes.  
A method is presented for searching needle placements that couples finite element 
models of radiofrequency ablation together with a novel optimization strategy.  The 
method was designed to reduce the need for model solutions per local search step.  The 
optimization strategy was tested against scenarios requiring single and multiple ablations.  
In particular, for a scenario requiring multiple ablations, a domain decomposition strategy 
was described to minimize the complexity of simultaneously searching multiple needle 
placements.  The effects of nearby vasculature on optimal needle placement were also 
studied.  Compared with geometric planning approaches, finite element models could 
potentially deliver needle placement plans that provide more physically meaningful 
predictions of therapeutic outcomes. 
 
Introduction 
Focal thermal ablative techniques have become widely adopted for the treatment 
of solid tumors.  Examples include laser ablation [65], cryoablation [66], high intensity 
ultrasound [67], and radiofrequency ablation [15].  For ablation treatments to be 
successful, the extent of the ablated volume must overlap entirely the detectable tumor 
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volume as well as a suitable margin that contains possible occult disease.  Although the 
physical mechanism of heat generation differs with each modality, the extent of the 
resulting ablation depends for all cases on the placement of the ablation device with 
respect to the targeted treatment volume.  Consequently, controlling the placement of the 
device is a factor in producing successful ablative therapy. 
The focus of this study is on the application of radiofrequency ablation (RFA) in 
treating unresectable tumors of the liver.  RFA works by inserting electrodes directly into 
a cancerous lesion.  Radiofrequency currents (typically, 400-500 kHz) delivered through 
these electrodes produce resistive heating, and the resulting temperature increase causes 
focal thermal damage to the tissue.  In a typical application of RFA, temperatures reach 
upwards of 100°C in the immediate areas around the active electrodes.  Above a critical 
temperature (typically above 50°C), tumors undergo coagulation necrosis, caused by 
irreversible cellular damage in the form of protein denaturation and disruption of cellular 
membranes.  Cell death is considered instantaneous at around 60°C [21].  In the course of 
an RFA treatment, the volume of ablated tissue increases as heat conduction distributes 
higher temperatures further into the tissue.  In typical commercial RFA systems, a 3-5 cm 
spherical ablation zone is expected.  Nevertheless, ablation of large tumors has proven to 
be unreliable [28, 68] with high local recurrence rates.  Although multiple ablation 
strategies to create larger ablations have been employed clinically [69], the investigators 
cited a need for better intraoperative guidance, as well as an appreciation of local 
physiological factors that affect ablation outcome  
Treatment planning of RFA device placement attempts to determine the position 
and orientation of the device relative to the targeted tissue that would maximize the 
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therapeutic outcome as predicted by a model of radiofrequency ablation.  At present, 
models of radiofrequency ablation used in treatment planning have largely relied upon 
geometric assumptions of the final ablation extents, typically spheres or ellipsoids [34, 
44, 69, 70].  The observed size and shape of RF ablations in clinical data show, however, 
significant variability in size and geometry [71], and simulation studies using 
computational models of RFA have demonstrated dependence of ablation extents on a 
number of physical parameters [27, 58].  These variations in ablation extents represent 
phenomena not readily predicted by geometric shapes.  Further compounding this 
problem is the irregular distribution of thermal sinks in the liver, particularly vessels that 
are larger than 3 mm in diameter [32].  These vessels have been shown to remain patent 
during treatment, and their proximity to a treatment region reduces the local ablation 
extents.  Consequently, variability in ablation volume and spatial extent is expected even 
within a single patient as the device is placed in different locations within the target 
organ.  More recently, investigators have attempted to incorporate patient-specific 
anatomical information into planning, as well as propose methods for modifying the 
assumed ablation geometries in the presence of nearby vessels [70].  However, these 
methods are based on phenomenological approximations of the underlying physical 
processes, and thus make use of parameters that are not necessarily physically 
meaningful. 
In this paper, a method is presented which uses finite element models (FEMs) of 
radiofrequency ablation to predict ablation outcomes for the purpose of planning needle 
placement.  Currently existing computational models of RFA are used to evaluate static 
geometries.  The models will be extended to allow evaluations of multiple needle 
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placements via dynamic remeshing.  Then, a strategy will be described to optimize the 
FEM predicted ablation result over the space of allowable needle placements in a manner 
that minimizes the number of FEM evaluations. 
 
Methods 
 
Finite element model 
Model geometries 
The treatment domain and needle geometries used in all simulation experiments 
are shown in Figure II-1.  The needle is modeled after the RITA Starburst XL RFA 
device (Rita Medical Systems, CA) in which the expandable needles have been deployed 
to the manufacturer’s “2 cm” setting.  The positions of the tips of the nine tines were 
measured relative to the tip of the trocar housing the electrodes.  Then, circular arcs are 
used as skeletons to connect the tine tips to the trocar tip.  A circle 0.42 mm in diameter 
is extruded along the skeleton to generate the three dimensional tines.  
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The geometries each have a local coordinate system.  For the needle, the origin is located 
1.5 cm proximally from the tip of the center tine.  The z-axis is defined to be parallel to 
the shaft of the needle, and the y-z plane was arbitrarily chosen to contain one of the nine 
 
 
Figure II-1: (left) Wireframe model of the domain geometry in the global coordinate system. (right) Close up 
of the model to show, starting from top left and going clockwise: a 2.5 cm tumor, a 0.6 cm vessel, and the 
designated entry point for all needle placements,.  The centroids of each of the three objects are placed on the z 
= 5 cm plane. (bottom) The surface model of a commercially used ablation device, along with its local 
coordinate system.  The right most plot shows the  placement relative to other geometries, used in all 
simulation epxeriments 
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tines.  In the treatment domain, the origin is located at the centroid of the outer cylinder 
representing the human torso.  In simulation experiments, the tumor centroid is placed at 
coordinates (-10 cm, 0 cm, 5 cm).  If a tumor is modeled, it is has a 2.5 cm diameter.  In 
simulations involving vessels, a 6 mm cylinder running parallel to the global z-axis is 
placed such that its centroid is at coordinates (-8.6 cm, 0 cm, 5 cm) if no tumor is present, 
or (-8.35 cm, 0 cm, 5 cm) if a 2.5 cm tumor is present. 
The allowable needle placements were constrained to simulate current RFA 
needle placement techniques.  The needle is inserted through a prescribed entry point te 
(illustrated in Figure II-1), with the goal of reaching a destination point after determining 
the correct trajectory.  In all simulations, te is given the coordinates (-10 cm, -5 cm, 5 
cm).  The depth of insertion and the orientation of the needle relative to the entry point 
are then allowed to vary freely, giving only 4 degrees of freedom as all transformations 
applied to the needle are assumed to be rigid about the origin of the needle.  Thus, for any 
point x given in the local coordinates of the needle, the transformation, T , to the global 
coordinates of the domain is defined by: 
 
 ( ) ( )ˆ eT R d= = − +y x x z t , (2.1) 
 
 
where d is the depth of insertion, zˆ corresponds to the axis of the needle, and R is a 
rotation matrix parameterized by sequential rotations about the x, y, and z-axes of the 
domain (i.e. ( ) ( ) ( )x x y y z zφ φ φR = R R R ).  To simplify future discussion, a parameter 
vector θ  is defined, whose elements are d and the three Eulerian angles: 
 
 , , ,x y zd φ φ φ =  θ . (2.2) 
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In all simulation experiments, θ  = [5.0 cm, 90°, 0°, 0°], resulting in a configuration 
shown in Figure II-1. 
For every new needle position in which the FEM model needs to be evaluated, the 
entire domain is remeshed.  A noncommercial meshing software package, Tetgen [72], 
was incorporated in order to generate volumetric meshes from an input surface mesh 
using constrained Delaunay tetrahedralization.  This software was further modified to 
include routines for repairing intersecting surface meshes that may result, for instance, 
from the needle penetrating other structures such as the outer boundaries of the domain or 
the internal spherical surface representing the treatment region.  Typically, 200 to 250 
thousand tetrahedral elements are generated in discretizing the domain, and 40 to 50 
thousand nodes are required. 
 
Constitutive equations 
Computational models of thermal ablation usually solve Pennes bioheat equation 
to obtain the transient temperature fields as a result of a local heat source: 
 
 ( )b a RFTc k T h T T Qtρ
∂
= ∇ ⋅ ∇ + − +
∂
, (2.3) 
 
 
QRF (W/cm2) is the heat source; T (°C) is the temperature; k (W/cm K) is thermal 
conductivity; ρ (g/cm3) is the tissue density; and c (J/g K), is the heat capacity.  The 
convective heat transfer coefficient, hb (W/cm3/K) models the rate of perfusion in the 
tissue, as arterial blood enters the tissue at a given temperature, Ta (°C), and is assumed to 
equilibrate immediately with the surrounding tissue.  The convective coefficient, hb, is 
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defined to be b b b bh c wρ= , where the subscript b indicates properties specific to blood, 
and wb is the perfusion rate (mL/mL/s).  All material coefficients are defined in Table 
II-1.  The heat source, QRF can be approximated by first solving the electrostatic problem 
with appropriate boundary conditions: 
 
 - 0σ∇ ⋅ ∇Φ = , (2.4) 
 
 
where σ (S/cm) is the conductivity of the medium, and Φ(V) is the electrostatic potential.  
Given Φ, the heat source is then estimated as the time-averaged power density generated 
by the resulting current: 2
0
1
2
set
RF
PQ P σ
 
 
 
= ∇Φ , where P0 is the input power resulting 
from 1.0 V applied to the needle, and Pset is the desired power setting. In order to solve 
the coupled partial differential equations, most investigators have employed the finite 
element method [53, 56, 73, 74].  FEM models for radiofrequency ablation typically 
solve the electrostatic problem over a single meshed domain that is shared with the 
thermal problem.  As a matter of convenience, a single mesh shared for both equations 
allows the estimated power deposition from the electrostatic equation to be coupled 
directly into the FEM formulation of the thermal problem without additional interpolation 
steps. 
 Boundary conditions are specified as follows.  For the electrostatic problem, the 
outer surface except the bottom face is prescribed an insulative, no flux condition.  A 
constant 1.0 V Dirichlet condition is applied on the conductive electrodes, and ground is 
placed on the bottom face.  The total power Pset was set to 20 W, and the entire ablation 
was run for 10 minutes, after which the power was set to 0 W.  For the thermal problem, 
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the cylindrical outer surface is given an adiabatic, no flux condition, whereas the top and 
bottom faces are preset to 37°C.  If a vessel is modeled, the vessel surface is also 
prescribed a constant temperature of 37°C. 
 
Table II-1: List of material properties used in RFA simulation.  Values represent the initial properties used 
in the simulations.  As simulations proceed, the temperature-dependent properties change. 
Properties Symbol (units) Value Reference 
Thermal conductivity (human liver) k (W/cm·K) 5.12e-3 [73] 
Density (human liver) ρ (g/mL) 1.06 [73] 
Heat capacity (human liver) c (J/g·K) 3.6 [73] 
Density (blood) ρb (g/mL) 1.0e-3 [73] 
Heat capacity (blood) cb (J/g·K) 4.18 [73] 
Perfusion  wb (mL/mL/s) 6.4e-3 [73] 
Electrical conductivity (human liver) σ (mS/cm) 3.33e-3 [73] 
Activation energy ∆Ea (J) 6.28e5 [75] 
Activation factor A (s-1) 3.1e98 [75] 
 
 
 
Finally, a measure of tissue damage accumulated over the course of the ablation is 
computed.  A suitable metric is the Arrhenius damage index, which has been previously 
employed by investigators [53, 75, 76] to predict the resulting thermal damage to the 
tissue.  In this work, a related parameter to the damage index, namely the survival 
fraction is used.  It is given by:  
 
 
( )
( ) ( )
,
exp ,
,
t EaA t
t RT t
ω
ω
 ∂ ∆
= − −  ∂  
x
x
x
, (2.5) 
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with the initial condition that ( )0, 1tω =x .  The Arrhenius survival function, ω, can be 
interpreted as the ratio of viable cells to total cells inside a region of space.  Thus, for 
ω = 1, the tissue is considered viable, and when ω << 1 the tissue is considered to have 
undergone coagulation necrosis.  In this work, the threshold used to demarcate the onset 
of coagulation necrosis is 10 eω
−
=  or approximately 37%. 
As suggested previously by other investigators [53, 55], this model implements 
temperature dependent electrical conductivity and perfusion to account for relevant 
property changes observed in clinical ablations.  The electrical conductivity of ionic 
solutions increases at a rate of 2%/°C [77].  On the other hand, perfusion decreases as 
temperature rises because of coagulation of microvasculature.  There is, however, no 
consensus model of how this behavior should be modeled.  In this work, the perfusion is 
scaled linearly by the local Arrhenius survival fraction ( ) ( )0, ,b bh t h tω=x x , in a manner 
similar to that proposed in [75, 78].  Thus, at the start of the simulation, the convective 
term is given in the table above, and tends towards zero as ablation proceeds.  The 
temperature dependence of other parameters has been neglected because their inclusion 
in the model would produce relatively small changes in the final temperature [79].  As the 
mesh is regenerated for each needle placement, routines are implemented to assign 
appropriate material properties to each tetrahedral element.   
In order to solve the system of equations, an external iterative solver package 
(PETSc, [80]) was used.  The transient temperature solution was obtained over 15 
minutes via a fully implicit time-stepping scheme with 15 second intervals.  
Temperature-dependent properties were updated by using the temperature distribution 
from the previous iteration.  A constant power setting was imposed on the electrostatic 
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problem.  At every time step, the electrostatic field was updated with the new 
conductivity properties.  The resulting power density was then scaled so that the total 
power in the domain was 20.0 W.  This setting was predetermined by so that the 
maximum temperature in the domain at the end of ablation, 10 minutes after start of the 
simulation, did not greatly exceed 100 °C.  After 10 minutes of ablation, the applied 
power was set to zero. 
 
Optimization algorithm 
Objective function 
In this study, the objective is to minimize the predicted Arrhenius survival 
fraction, ω, in a weighted sense everywhere in the region of interest (ROI), at the end of 
the simulation: 
 
 
( ) ( ), fROI W t dω= ∫ x x xJ , (2.6) 
 
 
 
in which the weighting term, W,  is given to be, 
 
 ( ) 1,
0,
tumor
W
otherwise
∈
= 

x
x . (2.7) 
 
 
 
The objective function as defined above represents the residual tumor volume that is 
viable after ablation.  MinimizingJ  is tantamount to reducing the chances that local 
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recurrence may occur because of residual tumor cells.  In the simulation experiments, the 
time to observe the Arrhenius was 5 minutes after power shut off, or tf = 15 minutes. 
 
Search method 
In order to search for the needle position that optimizes the given objective 
function, the resulting ablation zone for each needle position needs to be estimated.  A 
straightforward implementation would reevaluate the FEM model for each new needle 
position to recompute the objective function.  Because the FEM model is a 
computationally expensive process, however, a method is required to minimize the 
number of FEM model reevaluations.  In this work, the strategy is to approximate the 
FEM solution as a field that transforms rigidly with the needle.  In this manner, the 
problem can be recast as an image processing problem.  Computationally, the objective 
function (2.6) can be viewed as the correlation of two scalar volumetric images.  The first 
“image,” W, describes the relative importance of a point in the target domain in the 
objective.  The second “image,” ω, represents the likelihood of achieving complete 
ablation at a given position relative to the needle.  Thus, the optimal localization of the 
needle is one that transforms the ω image to be minimally correlated with the W image, 
subject to constraints given in (2.1): 
 
 ( ) ( )( )* arg min δ ; , fROI W t dω= ∫θθ x x θ xT  (2.8) 
 
 
 
where Tδ  is the incremental transformation from the initial transform of the needle, 
( )0θT , as given by 
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 ( ) ( ) ( )1 0δ −=θ θ θT T T . (2.9) 
 
Implicit in the proposed strategy is the assumption that the ablation shape does 
not change significantly over small perturbations of its orientation and position.  The 
justification comes from the observation that the RF power is deposited chiefly within a 
few millimeters [81] of the conductive electrodes, and in particular near the tips of the 
tines.  Thus, the regions of highest power density tend to vary closely with the position 
and orientation of the needle.  If the domain is homogeneous and the relevant boundary 
conditions sufficiently far away, then the resulting ablation shape would be largely 
invariant with respect to the needle position and orientation.  Nevertheless, in clinically 
relevant applications such as in the liver, there is in fact local material inhomogeneity, 
and thermal and electrical boundary conditions may be nearby.  Thus, spatial variability 
of the ablation with respect to the needle is expected as the needle is relocated during the 
search process.  To correct for deviations from the assumption in the image correlation 
problem, the finite element model is reevaluated periodically to update the image, ω. 
To implement this strategy described above, the following steps are taken.  At iteration, 
m, of the global search loop, the survival distribution, ωm, is obtained by reevaluating the 
FEM problem.  Then, ωm is sampled around the present orientation and position of the 
needle to form a discrete image, ωm   The samples form a 6 cm cubic Cartesian grid of 1 
mm cubic pixels, a size sufficiently large enough to capture the expected ablation extents.  
This “needle” grid is axis-aligned with the local reference frame of the needle and 
centered about the origin of the needle.  Sampling of the tetrahedral mesh at these 
transformed grid points requires multiple point location queries, which are facilitated by 
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construction of a search tree that sorted the tetrahedra of the meshed domain into 
rectangular bins.   
A second set of pixels is used to sample the weighting function, W, defined over 
the region of interest to generate the discrete image Wm.  These pixels from the “domain” 
grid are also sampled on a Cartesian grid of the same size as that of ωm, but are axis-
aligned to the global coordinates, and centered on the region of interest.  The algorithm 
then enters a local search loop, where at each iteration n of the loop a new set of 
placement parameters is determined in an attempt to minimize the discretized form of the 
objective function: 
 
 ( ) ( )( ), ; ,k n k k n ftδ=∑W x ω x θJ T . (2.10) 
 
 
 
When the transformed pixels of the image Wm do not fall on the grid points of the 
transformed image ωm, linear interpolation of the sampled grid is used to obtain 
corresponding values of ωm.   
The optimization method for the image correlation is steepest descent [82].  The 
gradient of the objective function, ∇
θ
J , is readily achieved analytically from (2.10).  
Termination of the optimization is based on gradient magnitude and relative change in 
sequential values of J .  Upon termination of the image correlation, the FEM model is 
reevaluated at the most recent value of θ.  In this manner, multiple rounds of FEM 
evaluation and image correlation minimization are performed until the search converges 
to a solution. 
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Figure II-2: Flowchart of optimization algorithm. 
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Termination criteria 
The global search loop, which includes alternating rounds of image correlation 
minimization and FEM evaluation, is terminated upon reaching the maximum number of 
iterations prescribed.  Experience with the algorithm suggests that typically no more than 
10 global search steps are required.  The search is also stopped if the maximum 
displacement of all tine tips is less than 0.01 cm between subsequent steps.  Finally, in 
order to prevent oscillatory behavior (i.e. sequential steps which produce oscillatory 
objective function values), the search is terminated whenever the current function 
evaluation exceeds the previous function evaluation.  This behavior occurs most often 
when the needle placement is already near a local optimum, at which point numerical 
noise (e.g. from FEM discretization and sampling of the solution) is the major contributor 
to variations in the subsequent function evaluations.  The algorithm is summarized in 
Figure II-2.  All algorithms were implemented in C++ on a Win32 platform using a 3.4 
GHz Pentium 4 processor with 2 Gbytes of RAM.  Runtime for a typical optimization is 
less than 2 hours. 
 
Simulation experiments 
Single ablations 
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In order to test the robustness of the optimization algorithm, the following 
evaluation method was devised.  An ablation was simulated with an initial needle 
placement, and the resulting ablation zone segmented using the ω0 threshold.  All of the 
points in this segmented ablation were designated to be “tumor”.  The initial needle 
placement was then perturbed along each of the four degrees of freedom, as reported in 
 
 
 
Figure II-3: (top row) Ablation outcomes of perturbed needle position.  The solid shape is the region 
corresponding to an ablation from an initially placed needle, whereas the translucent shape is the 
current ablation from a needle perturbed from the initial placement.  Shading of the ablation surface 
depicts unablated (black) and successfully ablated regions(white).  The three figures going from left to 
right depict the result from lateral, superior, and medial views.  (middle row) Recovered ablation result 
after optimization of needle placement.  Figures correspond to same view as in top row.  (bottom row) 
Comparison of perturbed needle position on the left, and recovered needle position on the right.  The 
lightly shaded needle is the original needle placement which created the solid ablation. 
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Table II-2.  For each perturbed needle placement, the optimization algorithm was 
executed to determine if the “tumor” region could be covered, and thus recovering the 
original needle placement.  This test was performed for two geometries, designated case 
1 and 2.  The only difference between the cases is the presence of a 6 mm vessel in the 
latter. 
 
Table II-2: Tabulated results of single ablation experiments. 
 Vessel absent Vessel present 
initJ (cm3) 0.43 0.40 
perturbedJ (cm3) 4.9 4.2 
optJ (cm3) 0.65 0.36 
( ), , ,x y zd φ φ φ∆ , perturbed 
(mm, deg) 
5.0 -9.57 5.73 5.73 5.0 -9.57 -5.73 5.73 
( ), , ,x y zd φ φ φ∆ , optimized 
(mm, deg) 
-1.0e-3 0.91 0.86 4.34 3.7e-2 0.10 0.21 8.10 
Mean
tinex∆ (mm), perturbed 9.1 9.1 
Mean
tinex∆ (mm), optimized 1.2 0.91 
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The optimization results for both cases were able to recover the original needle 
position to within millimeter accuracy.  The algorithm reported a lower objective 
function, optJ , than the perturbed function value, perturbedJ , and was comparable to the 
unperturbed initial value, initJ  (see Table II-2).  The result for case 1 (without the vessel) 
is shown in Figure II-3, and it is evident that the optimization program was able to 
relocate the needle so that the optimized ablation covered the initial ablated region.  
Despite this improvement, however, the result showed a slight asymmetry in coverage on 
the region surface, where one side is ablated more completely than the other.  In ablation 
 
 
 
Figure II-4: Same arrangement as in Figure II-3 except for the additional presence of a 6 mm vessel. 
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experiments where the optimization method was executed simply on the unperturbed 
needle (results not shown), the optimizer also generated similar asymmetry in the final 
ablation, as is reported here.  This result is likely due to numerical artifacts caused by 
sampling the FEM solution ω onto a Cartesian grid.  Because the survival distribution 
transitions sharply between 0 and 1 in space, the sampling process could cause a 
misrepresentation of the local ablation at the margin.  This problem may be resolved by 
increasing the resolution of the sampling grid, or by postprocessing the sampled image ω, 
such as applying smoothing filters.  Nevertheless, despite this sensitivity to sampling 
error, the results are still reasonable considering that this experiment represents worst 
case scenarios in which the “tumor” is as large as the ablation.  Furthermore it is not a 
consistent error, as comparatively speaking, the scenario for case 2 (with a vessel 
present), shown in Figure II-4, produced better results.  The results also show that 
ablations are fairly insensitive to rotation about the shaft of the device (i.e. φz).  
Consequently, the optimizer is generally unable to recover the original shaft roll. 
 
 
Figure II-5: Results from single ablation of 2.5 cm tumor with a nearby 6 mm vessel.  The surface map 
shows nonablated areas (dark shade) around the periphery of the tumor, particularly near the vessel.   
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Multiple ablations 
While using the same external geometry as in the single ablation experiments 
above, a 2.5 cm spherical treatment instead was placed 1 mm away from a 6 mm vessel.  
Optimal planning using a single ablation resulted in ablated regions on the periphery of  
the spherical tumor, as shown in Figure II-5.  In order to plan multiple ablations, the 
treatment region was first decomposed into three equal sections as depicted in Figure 
II-6.  Needle placement was optimized independently for each section, and the resulting 
ablations were combined by multiplying the individual survival distributions (or 
equivalently, adding the logarithm of the survival distributions).  Compared to the 
original single ablation, the results are markedly improved in which the predicted residual 
tumor volume is orders of magnitude smaller than for the single ablation case.  As listed 
in Table II-3, the combined ablations create an ablation that is nearly twice that of the 
tumor volume, and a 56% increase over the volume of the single ablation. 
Table II-3: Multiple ablation results. The target volume refers to the volume of either the tumor section 
or the entire tumor.  The last column describes the mean tine shift from the optimized single ablation 
placement. 
 
Target 
Volume 
(cm3) 
Ablation 
Volume 
(cm3) 
0J  
(cm3) 
optJ  
(cm3) 
mean 
tinex∆  
(mm) 
Ablation 1 3.1 10.5 .27 6.4e-6 5.9 
Ablation 2 3.1 12.1 .30 8.4e-4 3.8 
Ablation 3 3.1 11.8 .40 1.8e-4 4.2 
Combined 9.2 18.6 .97 2.5e-4 -- 
Single 9.2 11.9 .97 2.3e-1 -- 
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It should be noted that only three ablations were required to generate a larger 
ablation zone.  In planning with geometric spheres, investigators have noted that 
theoretically at least four ablation spheres are necessary to achieve an ablation of a 
spherical tumor that is larger than each ablation sphere [35].  The present result is 
possible because the predicted ablation geometry is shaped like a teardrop.  Compared 
with a sphere, the teardrop shape is elongated along the axis of the RFA device and thus 
 
 
 
Figure II-6: (top row) Schematic of decomposed tumor domains in order to facilitate multiple ablation.  
Ablation of each wedge is planned independently of the other.  (middle row) Results of ablation planning 
for wedges that correspond, going from right to left, to Ablations 1 to 3, as labeled above.  (bottom row) 
Combined ablations shown in lateral and medial views.  The right most figure shows the optimized needle 
placements. 
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is capable of covering wedge-shaped sections as used in this experiment.  Another 
interesting observation is the net change in needle placement to achieve the simulated 
outcome.  In geometric planning that uses spheres as ablation models, the plan would 
expect to place the probes symmetrically within a spherical tumor.  In the results 
described above, however, the arrangement of probes is asymmetric, with the probe 
ablating the section closest to the vessel being displaced furthest from the optimized 
single ablation placement.  The increase in displacement is needed to ablate the tumor 
margin closest to the 6 mm vessel, so that more power can be deposited near the vessel 
wall.   
 
Discussion 
In this paper, a method has been described to automate searches of optimal needle 
placement for radiofrequency ablation.  This technique potentially enhances the ability of 
clinicians to design patient-specific plans by using not only patient anatomy but also 
relevant parameters that are physically meaningful and predictive.  The method builds off 
of the theoretical observation that over small perturbations to needle parameters, the 
ablation shape varies slowly.  Thus, an efficient search method can be developed by 
assuming that the ablation shape transforms rigidly with the RFA device.  To account for 
real world scenarios in which thermal and electrical boundary conditions affect ablation 
shape locally, the search routine is updated periodically by reevaluating the RFA model 
to obtain a more accurate representation of the ablation shape.  In this manner, the RFA 
model continues to inform the search process, but the number of model evaluations is 
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minimized.  The results presented suggest that the method is capable of optimizing needle 
placement.   
A feature of the proposed optimization method is that it is independent of the 
specific FEM model used to predict the ablation outcome.  Indeed, improvements can be 
made to the model to include, for instance, a more detailed analysis of local blood flow 
[83] to account for the heat sink effect of vasculature.  Other commercial RFA probes 
may also be incorporated into the proposed search framework, along with the specific 
power control methods used in the design, since the method does not presume any a 
priori shape to the ablation.  This search strategy could itself be integrated into larger 
search problems that include additional surgically relevant problems.  For instance, in the 
method described, the entry point was fixed in the optimization scheme.  Nevertheless, 
the entry point may also be incorporated into the planning problem, in order to identify, 
for instance, the best trajectory to avoid critical organs or intervening vasculature.  In 
particular, this work could potentially enhance the planning framework previously 
presented by these investigators [70].  Another manner of incorporating this work into 
existing literature is in the use of multiple ablation planning strategies [34, 35].  Planned 
placements using, for instance, geometric shapes may be further refined using this 
framework by decomposing the tumor domain in a manner proposed in this work.  
Because FEM models may be able to predict physical phenomena that are not actually 
captured by geometric shapes, this framework can potentially be used to generate more 
efficient and accurate plans. 
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Conclusions 
A novel algorithm for planning optimal placement of a radiofrequency ablation 
needle was described.  The planning method coupled FEM models, rather than geometric 
shapes, with an efficient search strategy to determine a needle placement that improved 
therapeutic outcome over a given initial placement.  Simulation experiments 
demonstrated the feasibility of the approach in worst case scenarios when the tumor was 
comparable in shape to the ablation zone, and in cases where multiple ablations were 
required. 
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CHAPTER III  
 
 
 
CHARACTERIZATION OF TRACKED RADIOFREQUENCY ABLATION IN 
PHANTOM 
 
 
 
Abstract 
Accurate placement of the device used to perform radiofrequency ablation (RFA) 
is necessary for successful therapy of solid tumors.  In this work, a phantom system based 
on an agarose-albumin mixture was developed for evaluating optically tracked 
radiofrequency ablation.  Calibration of the tracked probe allowed positions of distal 
features of the device, notably the tips of the needle electrodes, to be determined to 
within 1.4 ± 0.6 mm of uncertainty.  Images acquired from ablation experiments 
performed using the tracked probe were compared to finite element models of RFA that 
used positional data of the RFA device obtained during ablation.  The model was able to 
predict 90% of pixels classified as being ablated.  Discrepancies between model 
predictions and observations were attributed to needle tracking inaccuracy as well as 
model parameter selection.  Results suggest the feasibility of using tracked RFA as well 
as finite element modeling to deliver targeted ablations with predictable outcomes. 
 
Introduction 
 Radiofrequency ablation (RFA) is currently a widely used treatment modality for 
unresectable hepatic tumors [15].  RFA produces focal therapy by delivering electrical 
energy directly into a cancerous lesion via needle electrodes.  Because active heating is 
limited spatially to within a few millimeters of the RFA needle [81], the therapeutic 
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efficacy of RFA depends on proper placement of the needle so that the final ablation 
extents would cover the tumor along with a suitable margin.  At present, needle 
placement is performed using intraoperative image guidance, typically with 2D 
ultrasound [23].  It has been recognized, however, that guidance with 2D ultrasound can 
be inaccurate [36, 38].  Investigators have described various strategies of improving 
needle localization intraoperatively including the use of optically-based and 
electromagnetic[84] tracking systems to determine the location of the device relative to 
the targeted lesion.  Various intraoperative imaging methods have also been reported 
including CT [37], and 3D ultrasound [39].   
Although guidance provides a means of delivering the needle device to an 
intended destination, it depends on having a preplanned needle placement which achieves 
the desired therapeutic goal.  Consequently, the success of therapy depends also on 
planning with a predictive model of RF ablations.  Presently, geometric shapes using 
spheres and ellipses have been employed to model ablations [34].  Geometric models 
provide a method for rapid planning of optimal trajectories, subject to constraints placed 
by the anatomy of the patient[70].  Nevertheless, geometric shapes are not sensitive to the 
actual physical parameters that govern ablations.  More sophisticated models have been 
studied that attempt to solve constitutive equations describing thermal ablations [53, 73].  
Use of these models to develop treatment plans, however, has not been explored, 
especially with respect to planning placement of the RFA device.   
This paper will study the problem of coupling positional information of a tracked 
RFA device with a computational model that predicts therapeutic outcome from physical 
principles that govern RFA.  The goal is to characterize the spatial extents of actual 
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ablations performed with tracked RFA in comparison to model predictions using the 
positional data from the tracking.  To achieve this goal, several pieces of technology, 
which until now investigators have studied independently, will be integrated together.  
First a tracked RFA device will be constructed and characterized for use in locating the 
functional components of the device within the coordinate frame of the treatment region.  
Then a phantom system will be developed to help visualize the ablation outcomes 
performed using the tracked RFA needle.  Finally, the phantom system will be imaged, 
and the ablation extents will be compared with finite element models of RFA solved 
using the measured needle positions as inputs.   
 
Materials and Methods 
 
Tracked RFA 
Needle holder design 
The ablation device used in this study was a RITA Starburst XL model 
radiofrequency ablation probe (RITA Medical Systems, CA).  In order to track the device 
in space, a rigid needle holder was constructed.  The needle holder served two primary 
functions. First, the holder reduced the bending of the RFA needle shaft so that during 
placement the needle shaft could be assumed to lie on a straight line.  Second, the holder 
provided a surface for infrared emitting diodes (IREDs) to be attached rigidly at places 
close to the distal tip of the device where the electrodes are deployed.  By localizing 
IREDS in space using an optical tracking system (Optotrak 3020, Northern Digital, Inc.), 
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real time information about the location of the needle holder, and thus the needle itself, 
were determined. 
 
Needle holder calibration 
The calibration of the needle’s physical location relative to the IREDs on the 
needle holder was achieved in two steps.  In the first step, the needle axis was determined 
with respect to the IREDs on the holder.  As shown in Figure III-1, the needle holder was 
constructed with a planar base so that it could be translated freely on top of a flat surface.  
Needle holes of the same diameter as the needle were drilled perpendicular to this base.  
A similar sized pivot hole was then drilled through an acrylic block on top of which the 
calibration experiments would be performed.  While spinning the needle holder around 
the shaft of a needle that had been inserted through both the needle holder and the pivot 
hole, multiple measurements of the IRED positions were acquired.  An average axis of 
rotation was calculated and this axis was used to define the local coordinate system of the 
                    
Figure III-1:  (left) Pictures of the needle holder designed to track the RFA device.  (right) Optical 
tracking camera similar to the one used to localize the IREDs on the needle holder (image from 
http://www.ndigital.com).  Image dimensions are not to scale. 
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needle holder.  In particular, the axis of rotation was presumed to align with the shaft of 
the needle, and was set to the z-axis. 
The second step in the calibration involved determining a fixed origin on the 
needle axis.  In order to proceed, an arbitrary origin was initially selected along the 
calibrated needle axis.  Using Optotrak, the transformed position of this origin was 
tracked as the needle holder was translated about the 
acrylic platform.  Then, a second previously 
calibrated and tracked stylus instrument was used to 
measure the same surface by sweeping the tip of the 
instrument over the surface.  Because both surfaces 
were measured in the reference frame of Optotrak, the 
distance between the two planar set of points was 
used to offset the initial point of origin along the 
needle axis. 
 
Tine coregistration 
A CT image of the RFA device while attached 
to the needle holder was acquired with the tines 
deployed at the manufacturer’s “2 cm” setting.  The locations of the 9 tine tips on the 
device were manually segmented and their positions in the image were recorded.  Four 
Acustar fiducial markers [85]attached to the needle holder (see Figure III-1 and Figure 
III-2) were also segmented, and their centroids were coregistered with Optotrak 
measurements of the corresponding points.  The coregistration step provided a means of 
Figure III-2:  Rendering of 
segmented CT image of RFA 
device attached to the needle 
holder, showing the deployed tines.  
The floating objects are the Acustar 
markers, while the H-shaped object 
near the top of the image is the 
frame that houses the IREDs. 
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transforming objects in the space defined by the Acustar markers to the space defined by 
the IREDs.   
 
Needle tracking experiment 
To characterize the ability of the needle holder apparatus to track the tip of a 
needle, experiments were performed using a hollow bore, 16 gauge needle (Popper and 
Sons, NY) as a proxy for the RFA device.  The needle was attached to the tracked needle 
holder and inserted into various locations within a rigid PVC box.  On the surface of the 
box were placed four Acustar fiducial markers.  The box was filled with a 3% gelatin 
solution (275 Bloom, Type A, Vyse Gelatin Co., IL) to provide a solid medium into 
which the needle is inserted.  With each needle placement, the position of the needle 
holder as measured by Optotrak was recorded, and then about 1 mL of a barium sulfate 
suspension (Lafayette Pharmaceuticals, IN) was injected into the gelatin.  The barium 
provided a record of where the needle was placed in the box when imaged by CT.  A total 
of 86 needle placements were recorded.  The average distance from the needle tip to the 
origin of the needle holder was 9 cm. 
In order to locate the needle tip within the CT image of the gelatin, a series of 
rigid transformations were computed to convert measurements in Optotrak coordinate 
system to the local coordinate system of the PVC box: 
 
 
needle PVC needle holder holder opto opto PVCT T T T→ → → →=  (3.1) 
 
The transformation 
needle holderT →  was determined in the previous section; holder optoT →  was 
reported by the Optotrak system after each needle insertion into the gelatin phantom; and 
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opto PVCT →  was constructed by coregistering the physical locations and the CT 
segmentations of the Acustar markers, in the same manner as described in the tine 
coregistration step above. 
 
Figure III-3: (left) Rendering of barium tracks imaged in CT.  An acustar marker is shown on the left. 
(right) Schematic showing between needle tip location predicted by Optotrak measurements, and the needle 
track segmented in the CT image. 
 
Segmenting the barium tracks proceeded with the following thresholding scheme.  
For each barium track, pixel values greater than 1300 Hounsfield units were identified.  
Using the Optotrak measurement as a guide, the search was constrained to a trajectory-
aligned cylindrical neighborhood around the needle tip location.  The cylinder was set to 
be 3 mm in diameter.  All other pixels were discarded.  The needle trajectory was then 
corrected by pivoting about the measured origin of the needle holder until the average 
weighted distance from each pixel to the trajectory was minimized.  The distance was 
δ 
Barium 
needle 
track 
Predicted 
needle 
track 
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weighted by the pixel intensities so that the trajectory would preferentially fit the higher 
intensity pixels produced by the concentrated barium suspension. Finally, a tip location 
was selected by searching the most distal pixel within a 1 mm diameter of the trajectory.   
 
Phantom experiments 
Ablations 
Ablations were performed in a rectangular acrylic box (4 in. x 3 in. x 4.5 in.), 
designed with needle holes on the top surface (see Figure III-4).  The needle holes were 
placed along the midline of the box.  These holes served both as physical markers to 
collocalize with the model in subsequent analysis, and needle guides for controlled 
placement.  This coregistration produced a transformation that mapped the coordinates 
from the Optotrak to the local coordinates of the phantom: opto phantomT −> .   
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Figure III-4: (top left)Photograph of the phantom housing along with the needle holder and the RFA 
device in a setup representative of the ablation experiments.  (top right) A close up of the phantom housing 
showing the needle holes, the slice guides used to aid in cutting the phantom, and the location of the 
grounding pad.  (bottom left)Schematic showing inner dimensions of the phantom housing and itslocal 
coordinate systems.  The phantom material is filled from the bottom up to an approximate height of 6.5cm. 
(bottom right)Top-down view of the phantom housing.  The dark circles represent the needle holes.  The 
dark lines show the location of the slice planes.  From top to bottom, these planes are y = 5, 0, -7, and -9 
mm.  
 
The box was filled with approximately 600 ml of a tissue-mimicking agarose-albumin gel 
adapted from[86].  The gel was composed of agarose (1% w/v) mixed in with liquid egg 
white (Country Creek Farms, AR).  According to the manufacturer, a 450 mL product 
y 
x 
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contained roughly 50 g of proteins, of which albumin is presumably a large component.  
In making these gels, the agarose solution was prepared initially at a higher concentration 
and cooled to approximately 50 °C.  The egg white solution was warmed to 
approximately 45 °C, before mixing in the agarose.  This step prevented the albumin 
from being prematurely denatured by the warmer agarose solution, but also allowed the 
agarose solution to remain above its gelling temperature.  The entire solution was then 
refrigerated for at least 6 hours. 
Two ablations were performed each with constant power settings at 20 W for 10 
minute using a RITA 500 RF generator and the RITA ablation device.  Temperature 
measurements of the tines were manually recorded at approximately 15 second intervals.  
The first ablation (designated “Case 1”, in the remainder of this document) was 
performed with an initial background temperature of 23°C and an impedance of 26 Ω, as 
reported by the RITA RF generator.  The device was placed through the second needle 
hold to the left of the center needle hole, as shown in Figure III-4.  The second ablation 
(“Case 2”) was performed at 27°C, also with an impedance of 26 Ω.  This ablation was 
performed in the same phantom as in Case 1, but occurred after 1 hour of cooling time to 
allow the phantom material to return to baseline temperatures.  The device was placed 
obliquely into the ablation to approximately the same depth as the first ablation. 
 
Photogrammetry 
After ablations were performed, the agarose-albumin block was sectioned 
manually with parallel cuts located at the planes shown in Figure III-4.  These sections 
were then photographed digitally into images of 1280x960 resolution.  The resulting 
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images were rescaled so that the width of the imaged phantom corresponds to the inner 
diameter of the phantom housing.  Finally, the images were realigned so that the edges of 
the phantom in each image match. 
 
Computational Model 
A finite element model was developed for the phantom system in order to 
determine if the ablation results could be predicted by computational modeling.  In 
particular, the model would be used to test if the the ablation extents align in space with 
images of the ablation outcome. 
 
 
Figure III-5: (left)The surface model of a commercially used ablation device, along with its local 
coordinate system.  (middle)A close up of the tine arrangement from the bottom.  (right)A surface mesh of 
the phantom geometry with a needle penetrating the phantom surface.   
 
Model geometries 
Shown in Figure III-5 is the surface mesh of the domain geometry and the needle 
model.  The model was constructed to mimic the dimensions of the acrylic box. 
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Excluding the RFA device, two material domains were used: one representing the acrylic 
box, and the other the phantom material.  The top surface of the phantom material was set 
so that the total volume would be 600 mL. 
The needle geometry was then placed according to the orientation and position 
provided by Optotrak.  To achieve this goal required the coregistraton of the needle 
geometry to the CT image of the physical device.  First the shaft of the needle was 
aligned with the segmented shaft of the CT.  Then, the tines of the needle geometry were 
coregistered with the tine measurements obtained earlier, producing the transformation 
RFA holderT → .  It should be noted that in the last step, the registration was constrained only to 
rotation about the shaft as well as translation along the shaft.  As in (3.1), the total 
transformation from the local coordinates of the RFA device to the coordinates of the 
phantom is then given by a series of transformations: 
 
 RFA phantom RFA holder holder opto opto phantomT T T T→ → → →=  (3.2) 
 
A mesh was then generated using a freely available meshing software package, Tetgen 
[72].  Special modifications were made to this software to allow repair of intersecting 
surfaces caused, in particular, by the insertion of the needle geometry through the surface 
of the phantom material. 
 
Constitutive equations 
Computational models of thermal ablation start with a thermal diffusion model: 
 
 RF
T
c k T Q
t
ρ ∂ = ∇ ⋅ ∇ +
∂
, (3.3) 
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where QRF (W/cm3) is the heat source due to RF currents, and T (°C) is the temperature.  
All other material coefficients are defined in Table III-1.  The heat source, QRF can be 
approximated by first solving the electrostatic problem with appropriate boundary 
conditions: 
 
 - 0σ∇ ⋅ ∇Φ = , (3.4) 
 
 
where σ (S/cm) is the conductivity of the medium, and Φ(V) is the electrostatic potential.  
Given Φ, the heat source is then estimated as the time-averaged power density generated 
by the resulting current: 2
0
1
2
set
RF
PQ P ησ
 
 
 
= ∇Φ , where P0 is the input power resulting 
from 1.0 V being applied to the needle, and Pset is the actual power setting, which is 20.0 
W.  The parameter η represents a phenomenological term that is used to account for 
unknown power losses due to inaccurate parameter selection and potential discrepancy in 
the power level reported by the RF generator.  This parameter was titrated using 1% 
increments starting from 100%, until the temperature distributions matched the predicted 
ablation in a control experiment.  This value has been set to 90% for all simulations. 
Boundary conditions are specified as follows.  For the electrostatic problem, the 
outer surface except the bottom face is prescribed an insulative, no flux condition.  A 
constant 1.0 volt Dirichlet condition is applied on the conductive electrodes, and ground 
is placed on the bottom face.  The total power Pset was set to 20 W, and the entire ablation 
was run for 10 minutes, after which the power was set to 0 W.   
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Table III-1: List of material properties used in RFA simulation.  Values represent the initial properties 
used in the simulations.  As simulations proceed, the temperature-dependent properties change. 
Properties Symbol (units) Value 
Thermal diffusivity (phantom) k (W/cm·K) 5.72e-3 
Density (phantom) ρ (g/mL) 1.03 
Heat capacity (phantom) c (J/g·K) 3.94 
Electrical conductivity (phantom) σ (mS/cm) 4.4 
Activation energy ∆Ea (J) 3.846e5 
Activation factor A (s-1) 3.75e57 
Thermal diffusivity (acrylic) k (W/cm·K) 1.7e-3 
Density (acrylic) ρ (g/mL) 1.19 
Heat capacity (acrylic) c (J/g·K) 1.4 
Electrical conductivity (acrylic) σ (mS/cm) 1e-14 
 
 
 
Finally, a measure of accumulated protein denaturation over the course of the 
ablation is computed.  A suitable metric is the Arrhenius damage index, which has been 
previously employed by investigators to model optical changes in albumin upon heating 
[86].  It is given by:  
 
 
( )
( ) ( )
,
exp ,
,
t EaA t
t RT t
ω
ω
 ∂ ∆
= − −  ∂  
x
x
x
, (3.5) 
 
with the initial condition that ( )0, 1tω =x .  The Arrhenius survival function, ω, can be 
interpreted as the ratio of undenatured proteins to total proteins within a given region of 
space.  Thus in the case of the phantom, ω = 1 corresponds to albumin in its native state, 
whereas ω << 1 indicates the albumin is denatured.  In this work, the threshold used to 
demarcate the denatured coagulum was set to 10 eω
−
=  or approximately 37%. 
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Material properties 
As suggested previously by other investigators [53, 55], this model implemented 
temperature dependent electrical conductivity.  In particular, the electrical conductivity of 
ionic solutions, notably that of the phantom material, increases at a rate of 2%/°C [77].  
The temperature dependence of other parameters were not modeled because their 
inclusion in the model would produce relatively small changes in the final temperature 
[79].  As the mesh was regenerated for each needle placement, routines are implemented 
to assign appropriate material properties to each tetrahedral element.   
A method for estimating the thermal properties was proposed in [86] based on the 
estimated water content of the material by mass, and adopted in this study.  The water 
content of the phantom was estimated based on the protein content (albumin) and agarose 
(56 g) as compared to the total mass of the gel (600 g), resulting in a ratio of 93%.  The 
electrical conductivity of the phantom was estimated to be 4.4 mS/cm at 23 °C based 
upon the impedance reported by the generator, and using the assumption that the material 
was homogeneous.  Finally, the Arrhenius parameters were those used in [86]. 
 
Iterative solver 
In order to solve the coupled equations, the finite element method (FEM) [53, 56, 
73, 74] was used to discretize the problem spatially.  An external iterative solver package 
(PETSc, [80]) was used to obtain the solution of the resulting systems of equations using 
an iterative scheme.  The transient temperature solution was computed over 15 minutes 
via a fully implicit time-stepping scheme, at intervals of 15 seconds.  Temperature-
dependent properties were updated by using the temperature distribution from the 
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previous iteration.  A constant power setting was imposed on the electrostatic problem by 
scaling the total power in the domain to 20.0 W at every time step.  After 10 minutes of 
ablation, the applied power was set to zero.  All algorithms were implemented in C++ on 
a Win32 platform using a Pentium 3.4 GHz processor with 2 GB of RAM.  For further 
details on the implementation, please see Chapter II. 
 
Model accuracy 
In order to evaluate the accuracy of the model two parameters were developed 
based on the pixels from the imaging studies of the phantom results.  The sensitivity, S, 
measures the ratio of the number of ablated pixels which coincide with the model, Noverlap, 
to the total number of segmented pixels, Nobserved: S = Noverlap / Nobserved.  The positive 
predictive value, P, measures the ratio of the overlap of ablated pixels with the model to 
the total number of pixels inside the model, Npredicted: P = Noverlap / Npredicted.  As an 
illustration, a large sphere that covers the entire region of interest would result in a S 
value of 1, but at the cost of a low P.  At the other extreme, a model that predicts a tiny 
spherical ablation in the middle of the observed ablation pixels would have a high P but a 
low S.  It is desirable to have high S and P values because it implies the model would be 
able to predict the observed ablation results with high probability without the model’s 
being overly permissive in predicting ablated pixels. 
In anticipation of needle tracking inaccuracies, a method was used to test whether 
the model accuracy would improve only by changing the position of the needle, while 
other model parameters remained the same.  Using an image processing technique 
previously described (see Chapter II), the RFA needle was repositioned from the 
 54 
 
measured placement with the objective of overlapping more of the observed pixels.  In 
addition, the model results were compared to spherical geometries commonly used in the 
ablation literature to model ablations. 
 
Results 
 
Needle tracking experiments 
 
Figure III-6: Histogram of the distance between needle tip location predicted by Optotrak and as observed 
in CT imaging. 
 
The average needle placement error was 1.4 ± 0.6 mm, and the figure above 
shows the calculated error distributions.  This result is comparable to a previous study 
using a similar barium track technique for evaluating needle tip tracking in gene therapy 
application [87].  One source of uncertainty in this experiment is the distribution of 
barium within the needle track.  Because gelatin tends to crack upon applied stress, the 
barium tracks may have extended further than the true needle tip position.  Indeed, if the 
needle length is considered fixed, then expected tip location as projected from the tracked 
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origin of the needle holder is consistently shorter than the tip location estimated from the 
CT image.  On average, this biased extension along the needle is approximately 0.8mm. 
 
Phantom experiments 
 
Figure III-7:  Ablation outcome for the slice at y = 0mm. 
Needle coregistration 
The registration error in RFA holderT →  used to map the tine tips of the physical needle 
to the needle geometry used in FEM modeling was 0.88 mm.  This result reflects 
discrepancies between the symmetric arrangement of the tines used in modeling 
compared with the actual asymmetries in the physical device.  Ideally, the geometry 
should match that of the physical device since electrical power is concentrated in the tine 
tips, and thus, accurate localization of the tine tips could potentially produce more 
accurate modeling.  Nevertheless this result is reasonable given the inherent difficulty in 
localizing flexible mechanical systems such as the tines in the RFA device. 
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Temperature traces 
 
Figure III-8: Temperature traces from (left) case 1 and (right) case 2.  The marked points are the recorded 
temperatures provided by the RFA system.  The solid lines represent the model predictions 
 
 The RITA RF system contains thermocouples embedded in the outer tines, and 
during the ablation experiments, these measurements were recorded manually.  The tines 
have been labeled to match the scheme used by RITA, in which tine 1 is the center tine, 
and tines 2 through 5 are the outermost tines, corresponding to the tines placed on the 
cardinal axes shown in Figure III-5.  As graphed in Figure III-8, the temperature 
measurements agreed with the model predictions well.  At higher temperatures, however, 
there is some deviation with the model, particularly visible in the plot for case 1.  This 
discrepancy is likely the result of additional dynamics, such as vaporization of water, or 
the desiccation of the phantom resulting in decreased power delivery locally.  The FEM 
model does not currently include these dynamics.  In both placements tine 1 is closest to 
ground, and hence is the path of least resistance for the RF current.  Thus, more power is 
preferentially deposited there.  Also of note is that even though the remaining 4 tines are 
arranged symmetrically about the axis of the device, there is some difference between the 
temperature distributions.  This difference is most noticeable in case 2, in which the tines 
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are placed at different distances from ground because of the oblique angle of insertion.  
The most straightforward explanation of these differences in local temperature is that 
they are the results of boundary effects. 
 
Image analysis 
The imaged ablation outcomes were segmented using a thresholding scheme.  The 
processed image corresponding to the slice plane y = 0 mm, as displayed in Figure III-7, 
is updated in Figure III-9.  The measured needle placements were generally in the right 
vicinity of the corresponding ablation for each case.  Furthermore the modeled ablations 
agreed with the imaged ablations.  The next sections provide quantification of this 
agreement. 
 
 
  
Figure III-9: Ablations at slice y=0 mm for (left pair) case 1 and (right pair) case 2.  The dark mask 
represents the segmented pixels corresponding to the ablated albumin.  The surfaces provide a three 
dimensional context of the overall ablation shapes.  The intersection of the surface with the plane is given 
by the black outline. 
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Model accuracy 
The results presented in the table demonstrate that with the raw measurements of 
needle position, the model is capable of predicting at least 90% of the pixels that had 
been classified as being ablated.  In achieving this result, however, the model predicted 
roughly 17-19% more pixels (i.e. from calculating the ratio of S to P) as ablated than than 
were classified as being ablated.  The overestimation of the ablation extents is likely a 
result of inaccurate model parameters.  On the other hand, the differences in S values 
between the two cases may be perhaps better explained by inaccurate needle tracking. 
 
Table III-2: Table of parameters characterizing model accuracy.  The bottom row lists the maximum 
displacement of a tine in the repositioning process. 
 Case 1 Case 2 
 Original Repos’d Original Repos’d 
SFEM 91.6% 99.1% 99.4% 99.9% 
PFEM 77.9% 82.6% 83.7% 81.8% 
Ssphere -- 81.5% -- 71.3% 
Psphere -- 100% -- 100% 
Max tine shift 1.4 mm 1.7 mm 
 
 
 
Needle repositioning 
Table III-2 lists the results from repositioning the needle in model simulations in 
an attempt to increase model overlap with observed pixels.  In both cases, the S values 
increased, an expected result since the goal was to increase the numerator of S.  In 
particular, with case 1, the data suggests that the needle tracking error was a major 
contributor to the reported inaccuracies as both S and P increased while the ratio of S to P 
slightly increased from 18% to 19%, suggesting that the modeled ablation could capture 
more pixels simply by reposition rather than by increasing its size.  In case 2, however, 
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there was a marginal increase in S while P decreased.  This result indicated that the 
algorithm positioned the needle in a manner that produced a larger ablation in order to 
overlap more ablated pixels.  Nevertheless the decrease in P was marginal, and the fact 
that both cases had roughly the same value of P suggests that some shared parameters 
used in modeling the ablations were likely affecting the overestimation of the ablation 
size.  These parameters may include discrepancies between true and simulated material 
properties, or the incorrect choice of threshold, ω0.  This latter prospect is further 
explored below.  It is of note that if the repositioned needle represents the true location of 
the physical device, then the amount of displacement of the tines is comparable to the 
error reported in the needle tracking experiment above. 
 
 
Figure III-10: The diagram shows, in the coordinate system of the phantom, the largest spheres that fit 
the ablated pixels, with the corresponding FEM prediction overlaid.  (left) Case 1. (right) Case 2 
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Comparison with sphere fits 
The results obtained with the repositioned FEM models were compared with 
spherical ablation geometries.  Each of the corrected ablation zones was fit with the 
largest sphere that was entirely contained within the observed pixels.  The results are 
shown in Figure III-10.  As can be seen, the sphere fits the fatter portion of the teardrop-
shaped ablation, but fails to account for the narrower portion near the shaft of the device.  
This observation is further illustrated in Figure III-11, in which the model accuracy was 
quantified using the S and P values described earlier.  For the repositioned FEM model, 
these curves were created by varying the treshold Arrhenius survival fraction.  For the 
sphere model, they were generated by varying the radius of the fitted spheres.  In general, 
in order to achieve an S value that is greater than 90%, the graphs show that the FEM 
model were able to do so at a higher P than using the sphere model.  In other words, if 
both model were fitted to capture 90% of the observed ablated pixels, the sphere model 
would cover more nonablated pixels than the FEM model.  Although these results may 
seem to favor FEM only slightly, it is worth mentioning that these phantoms do not 
include the effects of vasculature.  In those circumstances, FEM model may outperform 
spherical models more significantly because geometric models do not account for heat 
sink effects.  It remains to be seen if methods proposed in [10], may enhance predictivity 
of geometric models. 
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Figure III-11: Receiver operator characteristics of sensitivity, S, and positive predictive value, P, values 
using sphere and FEM ablation models for each of the two ablation results.  The curve was generated for 
the FEM model by varying the contour threshold, whereas for the sphere model, the sphere radius was 
varied. 
 
Conclusions 
In this paper, evidence was presented to support the use of tracked RFA device in 
producing ablations whose spatial extents are predictable by computational modeling.  
Needle placement experiments demonstrated the ability of the optical tracking system to 
localize functional features of the device, particularly the electrodes, in space.  Ablations 
were performed inside a phantom system with the tracked device, and the positional data 
of the device were used in computational models of the ablation.  Results from the 
simulations demonstrated the feasibility of the models in predicting at least 90% of the 
ablated pixels in images of the phantom.  
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CHAPTER IV  
 
 
 
SENSITIVITY ANALYSIS OF NEEDLE PLACEMENT IN RADIOFREQUENCY 
ABLATION PLANNING USING A BEM-FEM APPROACH 
 
 
 
Abstract 
A computational method is presented for optimizing needle placement in 
radiofrequency ablation treatment planning.  The parameterized search is guided by an 
objective function that depends on transient, finite element solutions of coupled thermal 
and potential equations for each needle placement.  A framework is introduced for 
solving the electrostatic equation by using boundary elements to model the needle as 
discrete current sources embedded within a finite element mesh.  This method permits 
finite element solutions for multiple needle placements without remeshing.  We 
demonstrate that the method produces a search space amenable to gradient-based 
optimization techniques.  The method is then used to analyze the sensitivity of the 
optimized needle placement to random perturbations in its position by means of Monte 
Carlo simulations.  The results of the sensitivity analysis demonstrate that localization 
errors decrease the effective ablation extent inside the treatment region.  Information 
from this analysis may be incorporated into clinical planning strategies. 
 
Introduction 
 Radiofrequency ablation (RFA) is used increasingly as a thermal ablative 
modality for treating unresectable liver tumors.  Needle electrodes deployed inside the 
tumor generate RF currents that result in the thermal destruction of malignant tissue with 
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minimal side-effects.  Nevertheless, success of RFA has been limited when treating 
tumors that are larger than 3 cm in diameter [28].  Computational models have become 
integral in understanding the roles that thermal and electrical characteristics of the liver 
[53] play in RFA treatment.  In addition, computational models that predict proper 
placement of the RFA needle have become the focus of significant research, particularly 
with regards to application of image-guided techniques [34]. In treatment planning of 
RFA, an important goal is the identification of suitable needle placements within the 
treatment region such that the therapeutic outcomes, as predicted by a model of RFA, are 
maximized.  Another goal is to take into account possible misplacement of the needle 
during implementation of the plan.  These localization errors in targeting a predetermined 
location within an organ are caused in large part by mechanical deformation of the organ 
[88], organ motion due to respiration [84], as well as intrinsic tracking errors in the 
surgical navigation system [43].   
Currently, models of RFA used in needle placement or trajectory planning 
typically assume that the resulting spatial extents are geometrically spheroid or ellipsoid.  
The goal in geometric planning is to arrange copies of these fixed shapes so that together 
they would cover a tumor along with a 1 cm margin [46].  It has been recognized, 
however, that geometric models of ablation may not be sufficiently predictive in 
situations where thermal sinks, produced by large blood vessels that remain patent during 
ablation, are close to the treatment area [31].  On the other hand, computational models, 
solved in particular by finite element methods (FEMs), are capable of producing 
predictive results based on physical laws that govern ablation [53, 55, 73].  Nevertheless, 
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little has been reported on how to incorporate FEM based solutions into treatment 
planning. 
An obstacle to using FEM models for treatment planning is that significant 
computational effort may be required to evaluate ablation outcomes from different needle 
placements.  One such burden is in preprocessing the model geometries in order to 
discretize the problem into a manageable system of equations.  In a straightforward 
implementation, a mesh would have to be regenerated for each new needle placement 
before the model can be solved.  Mesh generation, however, is indirectly a 
computationally expensive process, especially in meshes containing geometrical features 
that vary significantly in characteristic length scales.  In particular, with respect to RFA 
modeling, the diameter of the tines of the probe is typically much smaller than other 
objects, and thus requires much refinement during mesh generation.  This refinement 
causes solvers of the FEM models to expend disproportionate computational effort on 
solving variables in a relatively small region of space compared to the treatment volume.  
Another source of computational burden lies in the postprocessing steps that are required 
to compare solutions from different needle placements.  Depending on the meshing 
technique, meshes may differ significantly from even slight perturbations to needle 
orientation and position.  Thus, in order to compare results from remeshed solutions, 
additional interpolation steps need to be taken, for instance, by sampling irregularly 
spaced FEM solutions onto a regular Cartesian grid. 
For these reasons, a method will be presented in this paper that eliminates the 
need for remeshing and allows solutions of linear FEM models for varying needle 
positions to be solved efficiently.  The method uses a current-source representation of the 
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needle electrodes as opposed to a constant voltage representation.  The novelty in the 
approach is that the current source may be coupled into FEM with a fixed mesh by means 
of direct integration.  The current source distribution is solved using the boundary 
element method, which discretizes the electrostatic problem into a smaller, albeit more 
dense, system of equations than FEMs.  After describing the method, it will be coupled 
with an optimization routine to search various needle placements in a given domain.  
Then, the method will be integrated into a Monte Carlo simulation to study the sensitivity 
of the optimized placement to perturbations to its position in order to model effects of 
needle localization inaccuracies encountered in real world RFA applications. 
 
Methods 
Computational models of thermal ablation usually begin with Pennes bioheat 
equation to solve for the thermal distribution as a result of a local heat source: 
 
 ( )b a RFTc k T h T T Qtρ
∂
= ∇ ⋅ ∇ − − +
∂
, (4.1) 
 
where QRF is the heat source due to the radiofrequency current, T is the temperature, and 
explanations of other coefficients may be found in [73].  In radiofrequency ablation, QRF 
can be approximated by first solving the electrostatic problem with appropriate boundary 
conditions: 
 
 - 0σ∇ ⋅ ∇Φ =  (4.2) 
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where σ is the conductivity of the medium, and Φ is the electrical potential.  Given Φ, the 
heat source is then estimated as the time-averaged power density generated by the 
resulting current: 212RFQ σ= ∇Φ . In order to solve the coupled equations, most 
investigators have employed the finite element method (FEM).  FEM models for 
radiofrequency ablation typically solve the electrostatic problem over a single meshed 
domain, Ω, that is shared with the thermal problem.  As a matter of convenience, a single 
mesh shared for both equations allows the estimated power deposition from the 
electrostatic equation to be input directly into the FEM formulation of the thermal 
problem without additional interpolation steps.   
 
Current source representation 
The technique developed to minimize remeshing exploits a well-known duality in 
electrostatics and circuit analysis regarding voltage sources and current sources.  
Specifically, for a voltage distribution that results from applying a constant voltage 
source to the needle (i.e. a Dirichlet boundary condition), there is an equivalent current 
source distribution (i.e. a Neumann boundary condition) that will generate the same 
voltage distribution in the domain.  The advantage of this equivalence is that a current 
source can be handled in FEM techniques independently of the mesh.  The disadvantage 
is that the magnitude of the equivalent current source that would result in the correct 
voltage distribution is unknown.  In order to provide an approximation to the current 
source strength, another technique – the boundary element method (BEM) – is utilized.  
In order to simplify the development of the method, the following additional conditions 
are imposed.  The constitutive models described in equations (1) and (2) will be linear 
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with spatially homogeneous properties and solved in 2D domains.  In the electrostatic 
problem, the ablation needle itself is represented as a 1D shell (i.e. a linear curve) within 
the domain, Ω, while the inactive portions of the needle such as the shaft of the needle 
are not modeled.  In the electrostatic problem this latter approximation is acceptable, 
since the nonconductive needle shaft does not affect the current magnitude significantly.  
The needle is assumed to be a perfect conductor, and thus Dirichlet boundary conditions 
for the potential problem are prescribed on the needle.  In the thermal problem, the needle 
itself is assumed not to have a material effect on the temperature distribution beyond 
acting as a heat source.   
To help illustrate the methods, the prototype problem shown in Figure IV-1 is 
used.  The geometry of the prototype problem is a rectangular domain measuring 20 cm x 
30 cm.  For the thermal problem, the prescribed boundary condition for all edges of the 
rectangle is T = 37°C.  For the potential problem, the edges are insulated (i.e. 0n∇Φ ⋅ = ), 
except for the rightmost edge which is grounded at Φ = 0.  The region of interest (ROI) is 
a circle with a diameter of 4 cm containing the needle.  The needle is prescribed the 
boundary condition 0Φ = Φ , which is set so as to produce a predetermined power level.  
The blood vessel is given the fixed boundary condition T = 37°C. 
As mentioned above, to eliminate FEM remeshing during optimization searches, 
BEM is employed to solve an equivalent potential problem, the solution of which is a 
current source distribution that can be readily coupled with a static mesh FEM.  The 
equivalent problem is described by Poisson’s equation: 
 
 
B jσ−∇ ⋅ ∇Φ =  (4.3) 
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where j is a surface current source model that is only active on the boundary of the 
needle1.  For 2D problems, j is thus represented by a line source of infinitesimal width.  
Though the spatial distribution of j along the surface of the needle is initially unknown, 
the voltage distribution is constrained by the same Dirichlet boundary conditions as in the 
original Laplace’s model.  
 
Ω
Needle
Blood Vessel
Needle
Origin
 
Figure IV-1: (left) The geometry of the prototype problem;  (middle) the region of interest (ROI);  (right)  
closeup of the ROI shows the needle source elements embedded in the triangular mesh. 
 
BEM uses the following integral formulation of Poisson’s equation: 
 
 
( ) ( ) ( ) ( ) ( ) ( )
( ) ( )
ˆ, ,
,
BEM BEMc G q G ds
G j d
∂Ω
Ω
Φ = − Φ ∇ ⋅ +
Ω
∫
∫
y
y
x x x y y y x y n
x y y
, (4.4) 
 
where ( , )G x y is the Green’s function for potential fields in free space, q is the normal flux 
at a boundary, and ΦB is the potential.  For 2D potential problems, 
( ) 12, logG pi= − −x y x y .  The coefficient term, ( )c x , is defined to be ½ if x is on a 
boundary, and 1 if x is inside the domain and located on a current source.  
                                                 
 
 
1
  In the BEM literature, this equivalence, wherein boundary conditions are treated as sources embedded in the domain, 
is known as an indirect formulation.   
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In order to solve this integral equation, the current source and the boundary are 
divided geometrically into Ns and Nb elements, respectively.  The resulting discretized 
integral equation for each element produces a system of b sN N+  equations, which can be 
written in matrix notation: BHΦ = Gq + Bj .  Using the collocation method [89], the entry 
in row i and column k of the matrices G and B is the result of evaluating the surface 
integral of ( , )G x y along element k at the collocation point on element i.  On the other 
hand, the entries of the matrix H represent contributions from the boundary integral of 
( ) ˆ,G∇ ⋅x y n  along element k to the ith element. All integrals are evaluated analytically.  
As written in (4.4), the vectors ΦB, q, and j represent the boundary voltages, boundary 
fluxes, and source currents at the collocation points of the boundary elements.  It should 
be noted that the vectors contain both unknowns and knowns.  In particular, wherever an 
element is prescribed a Neumann condition, the corresponding component of ΦB needs to 
be solved.  Similarly, if a Dirichlet condition is prescribed, then the corresponding 
component of q needs to be solved.  All elements of j are unknown, and it is the object of 
this method to determine their values.  To proceed then, the unknowns are first collected 
onto the left hand side.  The resulting system of equations, which appears in the 
form Pα = b , is solved.  The solved variables are then resorted into the original vectors 
ΦB, q, and j to obtain the desired solutions.  For further details on implementing BEM, 
the following text is recommended [89].  A representative BEM solution is shown in 
Figure IV-2. 
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Figure IV-2:  (left) The graph depicts a representative current distribution along the needle solved using 
BEM with Φ0 = 163 V and σ = 1.48 mS/cm.  The resulting power density is shown for each element of the 
mesh (right). 
 
Power Density Estimation 
Once the boundary element problem is solved, an estimate for the current source 
model is obtained.  In order to estimate the power density, the current source model is 
used with FEM to estimate the potential everywhere else in the domain.  The standard 
Galerkin formulation of Poisson’s equation in FEM analysis is: 
 
 ( )F Fi i id n ds j dσ ϕ ϕ σ ϕ
Ω ∂Ω Ω
∇Φ ⋅∇ Ω − ∇Φ ⋅ = Ω∫ ∫ ∫

 (4.5) 
 
where
1
eN
F F
k k
k
ϕ
=
Φ = Φ∑ , and kϕ is chosen to be a piecewise linear basis function.  The right 
hand side of equation (4.5) is coupled to the BEM solution via the current source, j, 
which is composed of piecewise constant line elements.  In order to evaluate this domain 
integral, it is therefore necessary to identify which elements in the FEM mesh contain a 
line element representing the current source.  Two steps are required.  First, point-in-
triangle queries are used to identify which finite elements contain the endpoints of a 
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boundary element.  Then, the segments are partitioned amongst the finite elements by 
solving for the points of intersection between the boundary element and the edges of the 
finite element.  Both computational geometry problems have been well studied [90].  As 
can be seen in Figure IV-1, relatively few triangular elements of the FEM mesh contain 
line elements of the BEM mesh, and thus, efficient data structures can be used to speed 
the search for triangle-line intersections.  After the line sources are partitioned among the 
triangle elements of the FEM mesh, the source integrals in (4.5) can be evaluated via 
Gaussian quadrature, resulting in the following system of equations, written in matrix 
form: E E
F
Κ Φ = f .  After the nodal values are solved, the power density for the ith 
element is estimated by 
21
2
F
i iQ σ= ∇Φ , which is constant within the element for 
piecewise linear basis functions. 
In order to model RFA with a constant-power setting, the voltage applied to the 
needle, Φ0, was scaled so that the total power deposited in Ω was equal to a prescribed 
level.  Although other power delivery schedules like constant temperature settings are 
used in clinical applications, they are more difficult to simulate because of proprietary 
control logic designed by the manufacturers of the RFA system [91].  Nevertheless, 
adapting this method to time-varying power schedules should be straightforward.  A 
typical solution of the power deposition is shown in  
Figure IV-2.  Given the power deposition, transient solutions to the thermal 
problem can be obtained via the FEM formulation of the thermal problem:  
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which can be rewritten in matrix notation as T T Tt∂ ∂ = +M T K T f .  Because the FEM 
mesh needs to be generated only once and the models are linear and coupled only via the 
heat source, the FEM matrices KE, KT and MT need only be computed and stored once.  
Thus, for each step in an optimization search, only the vectors fE and fT need be updated.   
 
Needle placement optimization 
The Arrhenius survival function is a commonly used index for evaluating thermal 
ablation.  The index is the solution to a first order differential equation with a 
temperature-dependent rate constant:  
 
 
( )
( ) ( ),
,
exp
,
a t
t EA
t RT t
ω
ω=
 ∂ ∆
−   ∂  
− x
x
x
, (4.7) 
 
 
with initial condition, ( ), 10tω =x .  The variable ω  can be loosely interpreted in the 
context of thermal ablation to mean the ratio of viable cells to all cells.  Other parameters 
in the equation are explained in [53].   After ablation, a smaller value of ω everywhere 
within the tumor would indicate a higher likelihood of ablation success.  Thus, a suitable 
objective function can be defined by spatially integrating ω, evaluated at some fixed time 
tf after the beginning of ablation, over the region of interest (i.e. the tumor):  
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 ( ), f
ROI
t dω= Ω∫ xJ . (4.8) 
 
For each time step in solving the transient temperature distribution, ω is updated at each 
node of the finite element mesh.  The same basis functions used in solving the FEM 
problems are applied to interpolate the nodal values of ω.  Finally, quadrature can be 
performed over each element of the mesh that belongs in the ROI.   
Because the transient temperature distribution is a function of the heat source, the 
objective function in (4.8) is implicitly a function of the position of the 2D needle.  
Consequently, the objective function can be parameterized by three degrees of freedom 
describing a rigid transformation of the needle: the x and y positions, and a rotation φ  
about the origin of the needle.  If θ is defined to be the vector of these three degrees of 
freedom, then the optimization problem searches for θ that minimizes ( )θJ .  The search 
method employed is an unconstrained steepest descent algorithm [82].  The gradient of 
the objective function is estimated using a finite difference scheme with a step size of 
10-4.  In order to seed the search, the needle origin is arbitrarily placed inside the ROI so 
long as the entire needle lies inside the ROI.  The search terminates if the relative change 
in θ  or ( )θJ  between iterations were less than 10-3 or 10-4, respectively.   
 
Sensitivity analysis 
In order to study the sensitivity of the optimized needle placements, the x and y 
coordinates of θ are perturbed according to a Gaussian distribution, 
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[ ] ( ), ; , , ,opt opt x yprb G x y x y s s=θ .  The following two distributions are then computed.  
One is the expected Arrhenius survival distribution in the region of interest at the end of 
ablation: 
 
 ( ) ( ); [ ]prb dω ω= ∫x x θ θ θ . (4.9) 
 
The second is the frequency of obtaining an Arrhenius survival fraction below a 
threshold, ω0: 
 
 ( ) ( ) [ ];S S prb d= ∫x x θ θ θ , (4.10) 
 
where ( )S x  is defined to 1 wherever ( ) 0ω ω≤x , and 0 otherwise.  In this study, the 
tissue is considered successfully ablated at below ω0 = 0.01.  Level sets of S  thus 
represent regions in space for which ablations can be achieved at those confidence levels 
over all trial implementations of the plan.  For instance, if placement is perfectly 
accurate, then the 100% level set would coincide with the predicted ablation.  Integration 
for both distributions is performed using a Monte Carlo scheme, in which perturbations 
are drawn from a Gaussian random number generator. 
 
Simulation Experiments  
 
BEM-FEM validation 
In order to test the validity of the BEM-FEM approach described above, a model 
geometry with an analytic solution to the electrostatic equation was used.  The embedded 
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needle was given a 1.0 V Dirichlet boundary condition, whereas the entire boundary of 
the exterior domain was grounded.  The power distribution calculated by solving the 
electrostatic FEM using the BEM computed current distribution was compared with 
analytic solutions.  
 
 
Figure IV-3: BEM-FEM model validation using a geometry with two concentric circles.  (top) 
Temperature difference from modeling with BEM-FEM computed power distribution versus analytic 
power distribution (°C), shown for the entire domain.  (bottom left) The difference in BEM-FEM computed 
power distribution and analytic power distribution.  (bottom right) Analytic power distribution, shown 
around the circular needle. 
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The results are shown in Figure IV-3.  As seen in the figure, the error distribution 
of the BEM-FEM solution is dependent on the level of mesh discretization.  In particular,  
a)  
 
b)  
  
Case 1:  a) A plot of ( )10log ω x  for the initial placement and a contour plot of ( )10log ω x ; b) similar 
plots for the optimized needle placement. 
 
a)  
 
b)  
  
Case 2:  a) A plot of ( )10log ω x  for the initial placement and a contour plot of ( )10log ω x ; b) similar 
plots for the optimized needle placement. 
 
Figure IV-4:  Simulation results comparing initial and optimized needle placements for two domains. 
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elements that contain the BEM current sources have higher errors.  This error likely 
reflects the use of a linear basis function in the finite element solution.  In order to 
compare the effects of this error on temperature distribution, an ablation simulation was 
performed.  As described above, a constant power ablation was performed for 10  
minutes, and a temperature distribution was obtained at 10 minutes both for the power 
computed with BEM-FEM and with the analytic solution.  The difference in temperature 
distribution is shown in Figure IV-3.  The maximum reported temperature rise at the 
center of the domain was 32 °C. 
 
Optimization results 
Values for the constitutive properties used in our model are listed in [53], with the 
exception that perfusion is not modeled (i.e. hb = 0).  For the BEM problem, the boundary 
and current source were discretized into Nb = 200 and Ns = 360 segments, respectively.  
For the FEM problem, the ROI contained 1504 triangles out of 2623 used in the entire 
domain.  At each step of the optimization, the total power deposited in the domain was 
fixed at 15 W/cm for 10 minutes.  The Arrhenius survival fraction was then evaluated 6 
minutes (i.e. tf = 16 min.) after the power is shut off.  All algorithms were implemented 
using Matlab (MathWorks, Inc.) on a 3.4 GHz Pentium 4 platform with 2 GB RAM.  
Optimization was attempted for two cases using the prototype model, one modeling the 
effects of a nearby vessel and one without.  Computation times for all cases ranged 
between 10-15 minutes.   
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Table IV-1:  Changes in needle positions and objective function between initial and optimized results. 
Case ∆x (cm) ∆y (cm) ∆θ (deg) J0 Jopt Ablation Area (cm2) 
-vessel -1.16 0.08 -4.6 4.2e-2 6.2e-6 20.98 
+vessel -1.24 0.16 15.3 5.1e-2 5.6e-4 18.88 
 
 
The Arrhenius survival distributions for the no-vessel and vessel cases (Case 1 
and 2, respectively) are shown in Figure IV-4.  Changes in the optimization parameters 
and objective functions are tabulated in Table IV-1.  A comparison of the two cases 
shows that optimal placements depend on the presence of nearby thermal sinks.  In 
particular, with a nearby vessel, the optimal needle placement is deflected towards the 
vessel so that the tips of the tines, where the most amount of power is deposited, come 
closer to the vessel.  Despite this adjustment, however, some parts of the ROI around the 
vessel remain relatively undertreated (i.e. ω > 0.01).  Indeed, the value of Jopt is higher 
than in the no-vessel case.  Such a result could be potentially informative in an actual 
clinical scenario by prompting the need for a change in treatment strategy or additional 
monitoring of this region after ablation. 
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Finally, an observation of the four simulations reveals that the ablation zone is typically 
not centered about the centroid of the needle.  Indeed, the needle is typically placed to the 
left of the vertical midline of the ROI, and the ablation zone extends preferentially 
towards ground, located on the right-hand side of the domain.  These results suggest the 
potential importance of the placement of the grounding pad in addition to the placement 
of the needle in optimizing therapy. 
 
 
 
 
Figure IV-5: Results of Monte Carlo simulation in studying sensitivity of previously optimized needle 
placements to 5 mm Gaussian error in needle position.  (left column)  Thin solid lines represent level 
sets of S  depicted, from outer to inner contour, at 50%, 75%, 90%, and 99% confidence in achieving 
successful ablation.  (right column)  Thin solid line represents the mean ablation ω at the threshold 
level ω0.  Results are shown for cases with no vessel (top row), and a vessel (bottom row).  In all 
diagrams, the dashed line represents the original predicted ablation given by the threshold level ω0.  The 
thick circular geometries represent the tumor boundary and the vessel, and the optimized needle 
placement is depicted. 
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Sensitivity Analysis 
In a series of Monte Carlo simulations for each of the vessel and no-vessel cases, 
the Gaussian localization model was set with standard deviation parameters x ys s s= = , in 
which s was varied from 1.0mm to 5.0mm in increments of 1.0mm.  Thus, 5 simulations 
were performed for each domain, and each simulation took approximately 1-2 hours to 
perform on the platform described above.   Figure IV-5 shows the distributions of ω and 
S  for the case of σ = 5.0 mm.  As shown in both domains, the mean ablation extents are 
smaller than that of the initial predicted ablation, and the level sets of S at the highest 
confidence levels fail to overlap the tumor significantly.  An interesting observation in 
the case of the domain with a vessel is that the closest distance from the level sets of S  
to the initial predicted ablation zone is smaller near the vessel than elsewhere.  This result 
indicates that although the vessel deforms the ablation zone, its effect is spatially limited.  
Indeed, if the vessel were not there, it is likely that sufficient power is still being 
deposited near the vessel location to generate an ablation that would overlap that region.  
A possible explanation is that in all perturbations to the position, the needle tips, where 
most power is deposited, are oriented close to the vessels.  If perturbations to orientation 
are included, the efficiency of ablating near the vessel may decrease.  In Figure IV-6, the 
trends over all error levels are plotted.  A notable pattern in the trends is that the rate of 
decrease in expected ablation areas and tumor coverage is largely the same in both 
domains, despite the different geometries of the final ablation zone.  This pattern may be 
coincidental with only perturbing the position of the needle, but not its orientation.  As a 
result, the net effect is approximately the same as convolving the initial predicted survival 
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distribution with the Gaussian kernel used in the Monte Carlo simulation, which would 
smear the distribution out symmetrically in a manner that reduces the ablation margin.   
In general the results show that as the perturbations increase in magnitude, less of 
the tumor can be expected to be ablated with high confidence.  These results thus provide 
motivation for improving surgical navigation as an indirect means of achieving 
effectively greater ablation sizes by making a higher percentage of the predicted ablation 
zone more likely to be achieved per needle placement.  These results also indicate that the 
planning process may benefit from incorporating measures of placement sensitivity into 
the objective function (e.g. local gradient information).  Currently, the objective function 
decreases in value dramatically as soon as the entire region of interest is within the ω0 
level set.  Thus, the optimization routine terminates even if the margins of the tumor are 
close to the ω0 level set.  In a sense, the termination is premature because even though the 
local gradient magnitude has decreased below tolerance, further optimization is still 
possible.  For instance, in the case of the domain with no vessel, the roughly circular 
contours shown in Figure IV-5 are not concentric with the tumor.  An optimization 
 
Figure IV-6: (left) Areas of expected ablation outcome ω  and its overlap with the tumor, normalized 
by the initial predicted ablation area and the tumor area, respectively.  (middle) Areas of overlap 
between level sets of S and the tumor, normalized by the tumor area.  (right) Areas of level sets of S , 
normalized by the initial predicted ablation area.  In all plots, the solid line refers to the case with a 
vessel, and the dashed line to the case without. 
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method informed by sensitivity analysis may further reposition the needle, or may 
indicate additional ablations to be performed. 
 
Conclusions 
We have described a computational framework to optimize needle placement and 
demonstrated its feasibility in simulations.  The method aims to minimize remeshing as a 
means to reducing computational burden in order to evaluate model simulations for 
multiple needle placements.  This efficiency is achieved by incorporating a current source 
representation of the RFA needle, the distribution of which is solved by BEM.  This 
current source representation can be integrated into FEMs in a mesh-independent manner.  
In addition, we have adopted the framework to study the sensitivity of planning to 
localization errors.  The results show that uncertainties in needle placement effectively 
reduce the expected ablation extents.   
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CHAPTER V  
 
 
 
CONCLUDING REMARKS 
 
 
 
Summary of Research 
 The goal of this research was to develop and evaluate a framework to plan the 
placement of radiofrequency ablation device. In Chapter II, a method was created to 
search for the device placement that would maximize the therapeutic goal according to an 
Arrhenius survival distribution.  This work improved on conventional planning 
techniques, which rely on geometric assumption about the final ablation outcome, by 
coupling the search with finite element models of ablations.  Because the finite element 
models were based on constitutive equations describing the physical processes governing 
RFA, this approach had the potential advantage of using physically meaningful and 
relevant parameters to predict ablation outcomes.  Nevertheless, compared to using 
geometries such as spheres or ellipsoids, models based on FEM solutions were more 
computationally intensive.  Thus, a novel scheme was developed based on the assumption 
that over small perturbations to the device orientation and position, the overall shape of 
the ablation would transform rigidly with respect to the device.  Reducing the problem in 
this manner allowed the use of image processing techniques to maximize the overlap of 
the ablation extents with the designated treatment region.  Then, to relax the artificial 
constraint that the ablation shape is invariant with respect to position in order to account 
for actual changes in ablation shape that occur because of thermal and electrical boundary 
conditions, the ablation was periodically updated by resolving the entire system at the last 
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searched device position and orientation.  This method was evaluated both for single 
ablations and multiple ablations.  In single ablation scenarios, the method was tested 
using perturbation analysis that were intended to represent worst scenarios in which the 
treatment region was as large as the ablation itself.  Results suggested that the search was 
insensitive to roll about the axis of the needle, but was otherwise capable of determining 
a needle placement that covered the treatment region.  In the multiple ablation scenario, a 
strategy was developed to reduce the complexity of the problem by decomposing the 
region into separate regions, and planning for each subdomain individually.  The 
combined ablation was capable of ablating more completely than the single ablation.  In 
addition, this result was achieved with fewer ablations than theoretically possible in 
geometric planning approaches. 
 Chapter III described the development of a phantom system used to test the 
accuracy of the model presented in Chapter II, as well as to evaluate the ability of an 
optically tracked radiofrequency ablation device to predict the extents of the ablation 
spatially.  An agarose-albumin gel phantom was constructed which provided a rigid 
setting for ablation experiments to be conducted.  In order to track the ablation device, a 
needle holder was built around the shaft of the needle in a manner that would not 
interfere with the deployed electrodes.  Then, a series of calibration steps were described 
that mapped the location of these electrodes into the coordinate system of the phantom.  
Comparison between the modeled ablation and the imaged ablation showed that the 
model correctly predicted at least 90% of the pixels corresponding to coagulated albumin.  
This accuracy was achieved with the model labeling 20% more pixels ablated than were 
actually ablated.  To determine if these pixel misclassifications could be explained by 
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positional inaccuracy of the needle alone, methods from Chapter II were employed to 
reposition the needle to maximize the overlap between needle and ablation.  The resulting 
prediction accuracy improved to cover at least 99% of the imaged ablation, and the result 
was achieved with only a nominal increase in the ablation size.  This outcome hinted that 
the model was itself accurate, and that the model discrepancies were a result of device 
tracking errors. Analysis of the contours of the Arrhenius distribution showed that the 
contours tended to agree well with the morphology of the imaged ablation.  Further it 
suggested that the model overprediction may be a result of incorrect threshold choice.  
Comparison of the FEM model with spherical models also suggested that the FEM 
models tended to account for a higher percentage of the imaged ablation pixels than 
spheres over a range of threshold choices and sphere sizes. 
 Inaccurate placement of the needle, like those observed in Chapter III, motivated 
the development of the techniques in Chapter IV.  In this work, the goal was to study how 
uncertainties in needle placement affect the reliability of an ablation produced from a 
treatment plan produced in Chapter II.  In particular, the aim was to determine the subset 
of the predicted ablation region that would be expected at a prescribed confidence level.  
To achieve this goal, a Monte Carlo scheme was used to evaluate the models for multiple 
perturbations to an optimal needle placement.  As noted in Chapter II, however, the 
complexity of FEM models precluded the possibility of using this approach.  Thus, a 
reduced model based on FEM-BEM approach was implemented.  This method allowed 
the needle to be represented as a current source which could be directly integrated into a 
static FEM mesh.  Consequently, the preprocessing steps such as mesh generation and 
matrix assembly involved in FEM methods need only be done once.  The result from 
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coupling the FEM-BEM model to a Monte Carlo integration scheme was a probability 
distribution in space representing the percentage of Monte Carlo trials that achieved 
successful ablation at any given point in the treatment area.  As uncertainty increased, the 
region of the originally predicted ablation area that could be confidently ablated 90% of 
the time (i.e. over all trials) decreased by as much as 40%.  In comparing these 
probability maps from domains with and without a nearby vessel it was shown that 
regions near the vessel were potentially less sensitive to positional uncertainties than 
other regions of the treatment volume.  This result suggested that depositing enough 
electrical power near the vessel was potentially a means of producing ablations that were 
robust to uncertainties in placement.  In general, the sensitivity analysis also indicated 
that multiple ablation approaches may be required even when a single planned ablation is 
predicted to overlap the treatment completely. 
 
Future work 
 
Model improvements 
Models can be improved to handle more physical phenomena.  Of particular interest is 
further research into modeling the effects of vessels over the relevant clinical ranges, 
namely those that are greater than 3 mm in diameter.  Because the tissue near the vessels 
is mostly likely to be ablated marginally, a more accurate analysis of the heat transfer in 
that region could generate a better understanding of the ablation efficacy.  Additional 
high-temperature dynamics, such as water boiling and tissue desiccation may also need to 
be incorporated.  Model improvements may also be achieved by enhancing the 
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performance of any individual computational component of the framework.  In particular, 
the most computationally intensive step in FEM analysis remains the time-stepping 
scheme used in producing the transient temperature distribution.  Methods to solve the 
nonlinear time-dependent differential equation more efficiently may make tractable the 
coupling FEM of analysis to Monte Carlo analysis. 
 
Multiple ablations 
As indicated in this dissertation, planning multiple ablations is a complex problem and 
merits further study.  The proposed strategy of decomposing the region of interest into 
subdomains reduces the problem complexity to planning for single ablations.  In doing 
so, however, it is assumed that past ablations have no effect on subsequent ablations.  
There are potential problems with this approach.  First, irreversible changes occur during 
the course of an ablation.  Notably, perfusion in the ablated region remains suppressed 
because local microvasculature is destroyed.  Other permanent changes have been 
observed in the literature include an altered baseline thermal and electrical conductivity.  
Furthermore, in clinical applications, it is unlikely that the surgeon waits long enough for 
the local temperatures to return to body temperature, as is currently assumed in the 
proposed methods.  Having a higher initial temperature distribution means that 
subsequent ablations are likely to reach boiling temperatures more readily, a scenario in 
which the presented models become less predictive as additional dynamics come into 
play.  It may be important to incorporate these phenomena into the model in order to 
quantify the potential synergistic (or detrimental) effects of cumulative ablations. 
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In vivo validation 
Ultimately, this research should proceed into the operating room.  Before then, 
however, a number of studies may be required to evaluate the effects of perfusion on 
planning.  Although a phantom system such as the one described in this research is 
desirable, little is presently known on how to construct a perfused phantom mimicking 
organic models.  Consequently, in vivo animal studies are likely to be the best model 
system.  In these models, however, device placement becomes less well controlled, 
particularly because of difficulties in coregistering the target organ with the space of the 
tracking system. Research into navigation in soft-tissue organs such as the liver may help 
further inform the planning process.  In particular, sensitivity analysis to placement error 
may be better constrained to model the mechanics involved in targeting a deformable 
organ with poor anatomical landmarks to be used for coregistration.  Retrospective 
analysis may be a first step towards in vivo validation, where the needle is tracked during 
use, and then a model is executed based on the positional data to compare with post-
ablation imaging analysis.
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